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ABSTRACT 
 
In the last years new psychoactive substances, initially termed as legal highs, 
appeared on the market, at breakneck speed, leading to a crescent concern due to its 
high consumption as well as to the serious adverse effects that have been reported. 
Among the new psychoactive substances emerged the synthetic cannabinoids 
category, being the class of drugs most commonly used in the large group of synthetic 
drugs.  
Initially, the first synthetic cannabinoids that emerged in the market had 
therapeutic purposes, being administered even in hospitals. However, they were later 
removed from clinical practice, due to the knowledge of its negative effects. 
Nevertheless, similar compounds have appeared in the market with recreational 
purposes as legal alternatives to illegal substances.  
The pharmacokinetics and pharmacodynamics of synthetic cannabinoids are 
similar to Δ9-THC, exerting similar effects on users. Nevertheless, synthetic 
cannabinoids affinity for cannabinoid receptors is generally much higher when 
compared with Δ9-THC, which may result in adverse reactions and toxic effects that are 
not experienced during the use of Cannabis, namely to heavier episodes of psychosis. 
Moreover, since the action of synthetic cannabinoids has been shown to be 
negative for the users, it is important to identify the compounds that are inhaled when 
the cigarette containing synthetic cannabinoids is burned, in order to assess the real 
danger concerning the consumption of such substances. Thus, several techniques were 
developed and tested trying to identify such compounds.  
The investigation samples, containing synthetic cannabinoids have been subjected 
to temperatures from 100 to 6000C (at intervals of 1000C) in a muffle furnace in order 
to simulate the combustion process. However, due to the experiment, volatiles were 
lost and the only conclusion obtained with this method was a decrease of synthetic 
cannabinoids concentration, as the temperature was increased, noting the complete 
volatilization of the majority, when subjected to 400°C.  
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Next, a new method was developed, using an apparatus with a SPE column, 
enabling the simulation of the burning of cannabinoids and retention of new products 
formed within the column. The combustion products were analyzed by GC-MS. Using 
the mass spectrum of each compound and simulating the chemical breaks of the initial 
molecule of the synthetic cannabinoids, it was possible to identify new products, 
named combustion products.  
In short, it was concluded from this work that the consumption of synthetic 
cannabinoids not only becomes harmful because of the toxicity of cannabinoids 
themselves, but also because of new compounds formed after combustion. Some of 
these products may elicit toxic effects and excessive consumption of most of them can 
lead to serious consequences in the organism.  
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RESUMO 
 
Nos últimos anos surgiram no mercado, a uma velocidade alucinante, uma série 
de novas substâncias psicoactivas, inicialmente denominadas como “drogas legais” 
cuja preocupação se tornou crescente devido ao elevado consumo que se começou a 
fazer sentir, bem como aos elevados riscos que foram sendo descobertos, à medida 
que novos casos de intoxicação iam surgindo. De entre as novas substâncias 
psicoactivas que surgiram, destacam-se os canabinóides sintéticos, constituindo a 
classe de novas substâncias psicoativas mais consumida. 
Inicialmente, os primeiros canabinóides sintéticos que surgiram no mercado, 
tinham finalidades terapêuticas, sendo administrados até mesmo em hospitais, 
acabando mais tarde por sair de uso, devido ao conhecimento dos seus efeitos 
negativos. Entretanto, começaram a surgir no mercado compostos semelhantes mas 
com fins recreativos, como alternativas das substâncias ilícitas. 
A farmacocinética e farmacodinâmica dos canabinóides sintéticos são similares às 
do ∆9-THC, exercendo efeitos similares nos consumidores. No entanto, a afinidade dos 
canabinóides sintéticos para os receptores canabinóides é muito maior quando 
comparada com o ∆9-THC, fazendo com que possam ocorrer reacções adversas e 
efeitos tóxicos que não são sentidos aquando do consumo de Cannabis, 
nomeadamente a episódios de psicose profunda. 
Tendo em consideração o elevado risco referido para os canabinóides sintéticos, 
tornou-se importante identificar os compostos que são inalados aquando da queima 
do cigarro contendo canabinóides sintéticos, por forma a aferir acerca do verdadeiro 
perigo do consumo de tais substâncias. Assim, foram testadas e desenvolvidas técnicas 
que possibilitassem a identificação de tais compostos. 
Inicialmente as amostras em estudo, contendo canabinóides sintéticos, foram 
submetidas a temperaturas de 100 a 6000C (em intervalos de 1000C) numa mufla, por 
forma a simular a combustão das mesmas. No entanto, devido à perda de compostos 
voláteis aquando da análise, a única conclusão possível de obter com este método foi 
o decréscimo da concentração dos canabinóides sintéticos, à medida que a 
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temperatura aumentava, notando-se a total volatilização da maioria quando 
submetidos a 400ºC. 
Seguidamente foi desenvolvida uma nova metodologia, em que um equipamento 
contendo uma coluna de SPE, possibilitou a simulação da queima dos canabinóides e a 
retenção dos novos produtos formados no interior da coluna, que posteriormente 
foram analisados por GC-MS. A identificação dos fragmentos de massa (m/z) bem 
como a simulação teórica das quebras na molécula inicial dos canabinóides sintéticos 
permitiu a identificação de novos compostos, denominados produtos resultantes da 
combustão. 
Em suma, concluiu-se com este estudo que o consumo de canabinóides sintéticos 
não se torna prejudicial unicamente pela toxicidade dos próprios canabinóides, mas 
devido aos novos compostos formados após a sua inalação, sendo que alguns deles 
são potencialmente tóxicos, podendo o consumo excessivo da maioria deles levar a 
graves sequelas no organismo. 
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1.1 NEW PSYCHOACTIVE SUBSTANCES: 
AN OVERVIEW  
 
In the last years a growing number of novel psychoactive substances appeared 
in the legal market as recreational drugs. They are manufactured mainly in China, 
Pakistan and India and distributed all over the world (Aoun et al. 2014). Those 
substances are called legal highs or smart drugs and range from plant-based to 
synthetic compounds (Johnson et al. 2013). These novel substances comprise 
derivatives and analogues of cathinones or cannabis, falling into three categories: 
synthetic cathinones (bath salts), synthetic cannabinoids (spice or incense) and 
synthetic amphetamine-like drugs (Arnold 2013). Other authors divided these 
substances in three other groups: stimulants, depressants and hallucinogens; they 
comprise natural plants, synthetic substances and semi-synthetic substances 
originating from natural oils (Kapka-Skrzypczak 2011). 
These substances may differ in its chemical structures, potencies, half-lives, 
metabolism and severity of side effects (Zukiewicz-Sobczak et al. 2012). 
In the last years, the control of these drugs has been reinforced opening great 
challenges to analytical laboratories to provide rapid tests for detecting these new 
materials (AgilentTechnologies 2012). 
These products are usually available in various formats, as pills, roll-ups, 
incense sticks, herb mixtures, room fresheners, powders or even bath salts. They are 
mixtures of fragments of plants (herbs) added with extracts of other plants and 
synthetic chemical substances. The majority of these substances were not tested, 
neither in humans nor animals, before introducing in the market (Kapka-Skrzypczak 
2011).  Plant-products often contain more than ten herbal additives, which difficult the 
identification of each psychoactive constituent (Rosenbaum et al. 2012). Several 
research works performed on the botanical material showed that most of the plant 
species do not have psychoactive properties; instead, they are used to dilute the 
cannabimimetic compounds (De Brabanter 2013). 
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In Portugal, until some months ago the production and distribution of these 
products were out of control (Corazza et al. 2013). The past legislation did not forbid 
the production and the use of these substances. Recently, authorities started to create 
a new legislation that, instead of forbid the commercialization of substances 
containing some specifically compounds, prohibits the production, importation, 
exportation, advertisement, distribution, sale, possession or supply of new 
psychoactive substances, by the law-decree 54/2013 from 17th April, that “Shall define 
the legal regime of prevention and protection against advertising and trade of new 
psychoactive substances”. However, the producers easily circumvent these laws 
avoiding the detection or legal scrutiny (Johnson et al. 2013). One small tweak, a single 
molecular change, and an illegal synthetic drug could suddenly become legal again 
(Arnold 2013).  
Aoun et al. 2014 have compared the desired effects, toxicity and management 
in case of intoxication between synthetic cathinones and synthetic cannabinoids (Table 
1). The majority has written in the label “not for human consumption”. The fact, that 
most of these drugs are legal in many countries led the users to believe that they are 
safe for consumption. It is also referred in literature that consumption is very risky and 
could have short and long terms adverse consequences on users (Corazza et al. 2013). 
The synthetic cathinones and the synthetic amphetamine-like drugs are 
stimulants with similar effects, as dilated pupils, hypertension, hyperventilation, 
paranoia, agitation and hyperthermia. The synthetic cannabinoids have the majority of 
the effects previously referred, as well as tremors and seizures (Arnold 2013). The 
synthetic cannabinoids were the most common drug used in this group.  
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Table 1: Summary of desired and toxicity effects and management (Aoun, Christopher et al. 
2014). 
 
 Desired effects 
 
Toxicities Management 
 
 
Bath salts 
 
Stimulation 
Elation 
Friendliness Fluency 
Sexual arousal 
Perceptual Disturbances 
 
 
 
Sympathetic overstimulation 
Aggression 
Agitation 
Memory deficits 
Hallucinations 
Paranoia 
 
 
 
Supportive measures 
Low-stimulation 
environment 
Benzodiazepines, 
IV fluids 
Brief low-dose 
antipsychotics 
 
 
 
 
 
 
Synthetic 
cannabinoids 
 
 
 
 
 
 
  
 
 
 
 
Euphoria 
Relaxation 
Disinhibition 
Altered perception 
Altered consciousness 
 
 
 
Anxiety 
Mood dysregulation 
Memory deficits 
Hallucinations 
Paranoia 
Seizures 
Nausea/vomiting 
Diaphoresis 
Hot flushes 
Mydriasis 
Tremor 
Tachycardia 
Hypertension 
 
 
 
 
 
 
Supportive Measures 
Low-stimulation 
environment 
Benzodiazepines 
 
 
 
 
 
 
 
 
Salvia 
 
 
Trance-like state 
Hallucinations  
Sensory disturbances  
Synesthesia  
Extra-bodily experiences  
Elevated mood  
 
 
 
 
 
Depersonalization 
Anxiety 
Dysphoria 
Confusion 
Fear 
Headaches 
Drowsiness 
Tachycardia 
Hypertension 
 
 
Supportive measures 
Low-stimulation environments 
Benzodiazepines 
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1.2 SYNTHETIC CANNABINOIDS 
 
 
1.2.1 General considerations 
 
Synthetic cannabinoids have the same effect than ∆9-THC (∆9-
tethrahydrocannabinol), the main psychoactive substance in natural cannabis, which is 
extracted from marijuana. The synthetic cannabinoid pure form is solid, and to create 
the herbal products, producers dissolve them in a solvent, which is sprayed or brushed 
on a plant material not including tobacco or cannabis. The cannabinoids added to the 
plant material are ready to be smoked when the solvent is evaporated and the herbal 
material re-dried (Musah et al. 2012).  
Some pharmacodynamics studies shows that these compounds demonstrates 
cannabinoid receptor affinity ranging from several orders of magnitude greater than 
the affinity of ∆9-THC found in natural growing marijuana (Musah et al. 2012). 
Since the discovery of ∆9-THC, synthetic cannabinoids have been synthesized 
for biomedical investigation because of their therapeutic potential. Dronabinol and 
Nabilone were synthetic cannabinoid receptor agonists developed for clinical use. 
Since 2004, “street chemists” made a smokable herbal product named K2 or Spice, 
which were consider alternatives to marijuana (Cottencin et al, 2014). 
The name Spice, initially the most popular herbal product, quickly sees its name 
associated to all products related to synthetic cannabinoids. In fact, it is a specific 
herbal product added with a synthetic cannabinoid with marijuana-like effects. Spice 
became a very attractive drug, not just because of its effects, the “high” sensation, but 
also because its inability to be detected by the commercial drug tests (Johnson et al. 
2013).  
These products were sold online or in head-shops, and it can still be found for 
sale in online shops, as incense or air fresheners, (Kapka-Skrzypczak et al. 2011) in foil 
bags containing approximately 3g of dry plant material (Cottencin et al. 2014).  
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Relative to this type of substances, the starting doses for consume ranges 0.5-2 
mg and typical are between 2.5 and 20 mg.  The effects start after 0.5-2 minutes and 
the strongest effect is observed 3-5 minutes next the ingestion. The effects ended 
approximately 1-2 hours after (Adamowicz et al. 2013). 
 
 
Figure 1: Material and packaging typically found within Spice and K2 products (Font: (Seely, 
Lapoint et al. 2012)) 
 
The exact composition of these products is not known, although the “JWH” 
series of cannabinoids is the dominant set of cannabinoids detected. JWH is a group of 
compounds synthesized by Professor John W. Huffman. Another series of synthetic 
cannabinoids developed in the Hebrew University, is the HU synthetic cannabinoids, 
commonly classified as narcotics. In a similar way, AM cannabinoid series refers to 
professor Alexandros Makriyannis, who developed it. After the recognition of 
pharmacological properties of these products, Pfizer pharmaceutical industry has 
synthetized another group of cannabinoids, the cyclohexylphenol family (CP). The 
Sterling Winthrop Pharmaceuticals industry was responsible by the synthesis of 
another group, the WIN synthetic cannabinoids. (Brabanter 2013). 
John W. Huffman demonstrated that a simple alkyl chain could replace the 
aminoalkyl group, by the analysis of JWH compounds. These compounds are 
characterized by their binding affinities for CB receptors (Favretto et al. 2013).  
JWH compounds have been classified into 5 groups: group 1 that include 
naphthoylindoles and is typified by JWH 018 including 73 other compounds; group 2, 
named naphthylmethylindoles that contains 9 compounds; group 3 including 
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naphthoylpyrroles in which several of the 32 known are potent CB receptor agonists 
(e.g., JWH 147) and therefore have a high abuse potential; group 4 termed 
napthylmethylindenes that has 3 members, as JWH 176 and finally the group 5 named 
phenylacetylindoles, covering 28 synthetic CBs, like JWH 203 (Favretto et al. 2013).  
 
 
 
1.2.2 Physico-chemical properties 
 
Synthetic cannabinoids are lipid soluble, non-polar molecules and highly 
volatilized compounds that contain 20 to 26 carbon atoms mimicking the structure of 
∆9-THC. According to each chemical structure they can be divided into three different 
classes: classical cannabinoids, non-classical cannabinoids, hybrid cannabinoids, 
amonialkylindoles, eicosanoids and others (Table 2). Each psychoactive substance is 
produced by altering the molecular structure of it precursor without eliminating the 
psychoactive effects (Honorio et al. 2014). 
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Table 2: Classes of synthetic cannabinoids according to the chemical structure by UNODC 
(adapted by (De Brabanter 2013)). 
 
 
Class of synthetic 
cannabinoids 
 
Chemical structure 
 
Molecular structure 
 
Examples 
 
 
 
Classical cannabinoids 
 
 
 
 
Structurally related to THC 
from Cannabis sativa 
  
 
 
 
THC; 
 HU-210; 
AM906 
 
Non-classical 
cannabinoids 
 
Cyclohexylphenols or 3-
arylcyclohexanols 
 
 
 
CP-47,497-C8; 
HU-308 
 
 
 
 
 
 
 
 
Hybrid cannabinoids 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Structural combinations of 
both classical and non-
classical cannabinoids 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
AM2201; 
MAM2201; AM-
4030 
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Eicosanoids 
 
 
Endocannabinoids and 
synthetic analogs 
 
 
 
 
Anandamide; 
Methanandamide 
 
 
 
 
 
 
 
Aminoalkylindoles 
 
 
 
Naphthoylindoles;  
 
 
 
 
 
Phenylacetylindoles;  
 
 
 
 
 
Naphthylmethylindoles;  
 
 
 
 
 
 
Benzoylindoles 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
JWH-122 
JWH-018; 
JWH-073 
 
 
 
 
 
 
JWH-250; RCS-8; 
JWH-203 
 
 
 
 
JWH-175; JWH-184; 
JWH-185 
 
 
 
 
 
AM-630; AM-2233; 
RCS-4 
 
 
Others 
 
 
Diarylpyrazoles, naphtoyl-
pyrroles, etc. 
 
 
 
JWH-307; CRA-13 
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In the commercialized products containing synthetic cannabinoids, it can also 
be found: fatty acids and their esters (linoleic acid, palmitic acid), amide fatty acids 
(oleamide, palmitoylethanolamine), plant-derived substances (flavors compounds), 
preservatives (benzyl benzonate) and additives (alpha-tocopherol). They may also 
contain vitamin E and are frequently contaminated with β2-adrenergic agonist 
clenbuterol, producing the known sympathomimetic-like effects (Seely et al. 2012). 
 
 
1.2.3 Pharmacokinetics and 
pharmacodynamics 
 
 
Although the pharmacokinetic and pharmacodynamic profiles of synthetic 
cannabinoids are not completely known, some studies reported oral and inhalation 
bioavailability, and no cases of parenteral or rectal routes of administration have been 
referred (Seely et al. 2012). 
Concerning to pharmacokinetic aspects, some studies were performed with 
JWH-018. The maximum concentrations were found five minutes after smoking, 
meaning that the absorption via lungs and the distribution over the other organs takes 
place quickly. The compound is detectable until 48 hours after the consumption. In 
general, these compounds are extensively metabolized in the human body (De 
Brabanter 2013).  
Some studies about the aminoalkylindole compounds described a lot of 
modifications occurring after the administration, as multiple hydroxylations, 
carboxylations, dehydrogenations, dealkylations and dehydrodiol formation. It was 
also showed that these metabolites are excreted as glucuronide and/or sulphate 
conjugates in urine. Monohydroxylated and carboxylated metabolites are also found in 
urine in high quantities. Some studies indicate that hydroxylation and carboxylation 
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are the preferred pathways of synthetic cannabinoids metabolism (Adamowicz et al. 
2013). 
JWH-018 is an example of a synthetic cannabinoid (figure 2) having a short half-
life in human blood following smoking (Teske et al. 2010). Nevertheless, specific 
metabolic pathways leading to detoxification and excretion remains to be determined 
(Gronewold and Skopp 2011). Specific cytochrome P450 enzymes responsible for the 
metabolism of the synthetic cannabinoids are not identified (Chimalakonda et al. 
2011), but it has been reported that the major UDP-glucuronosyltransferases 
responsible for conjugation are UGT1A1, UGT1A3, UGT1A9, UGT1A10 and UGT2B7 
(Seely et al. 2012). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2: Summary representation about JWH-018 metabolism, excretion and potential 
downstream interactions with CB1 receptors and other physiological targets (Font: (Seely et al. 
2012)). Legend: “+” indicates agonism; “-“ indicates antagonism; “X” indicates no binding 
affinity and “?” indicates not known) . 
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Based in user reports, some synthetic cannabinoids act like marijuana whose 
principal active is ∆9-THC. Hence, the hydrophobicity of a compound (as measured by 
its distribution coefficient, log D) affects strongly its pharmacokinetics and 
pharmacodynamics. The log D values indicate that synthetic cannabinoids are highly 
lipophilic and their absorption, distribution, metabolism and excretion are similar to 
∆9-THC. This lipophilic characteristic favours the absorption of the cannabinoids across 
the lipid bilayer membranes, favoring the quick elimination from blood circulation. It 
can be expectable that after the consume of similar doses of synthetic cannabinoids 
and ∆9-THC, the levels of blood and urine can be comparable (Adamowicz et al. 2013). 
In conclusion to the pharmacokinetic aspects, it is possible to affirm that the 
diverse metabolite activity profile of aminoalkylindole metabolites may partially 
explain the mixed effects of this kind of drugs and their high potential safety concerns 
(Seely et al. 2012). 
In respect to pharmacodynamics, it is known the presence of two cannabinoid 
receptors in the human body, named CB1 and CB2 receptors. The CB1 receptor is 
located in the brain and in the central nervous system, expressed presynaptically, 
decreasing the release of GABA and increasing the extracellular glutamate and 
dopamine neurotransmitters levels (Seely et al. 2012), what makes the activation of 
this receptor responsible for the psychotropic effects. CB2 receptor is essentially 
present in immune cells and has an effect in the inflammatory process, the release of 
cytokines and cell migration (Rosenbaum et al. 2012).  
Both are G-protein coupled receptors responding to endogenous ligands 
anandamide and noladin ether and also to synthetic cannabinoids and ∆9-THC 
(Rosenbaum et al. 2012). The activation provokes presynaptic hyperpolarization 
through changes in calcium influx and potassium efflux resulting in neuronal 
hyperpolarization and a decrease in neurotransmitter release (Seely et al. 2012).  
Although chemical structure of synthetic cannabinoids and ∆9-THC structure are 
considerably different, both are agonists of the cannabinoid receptors and may exert 
activity on other receptor families. The affinity of the most cannabimimetic 
compounds is considerably higher, especially with the CB1 receptor, comparable to ∆9-
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THC (Adamowicz et al. 2013), but also for the CB2 receptors, hence the synthetic 
cannabinoids, with affinity for this receptor can affect the immune system by 
modulating chemotaxis of T lymphocytes or inducing thymic atrophy and apoptosis 
(Seely et al. 2012). 
The prolonged use of synthetic cannabinoids compared to consume of 
marijuana is strongly related to persistent psychosis, because of its major affinity of 
the cannabinoid receptors and the high potency of compounds found in these 
products. In other hand, marijuana has in its composition cannabidiol, an antipsychotic 
compound that provokes a decrease of psychotic activity (Aoun et al. 2014). 
The knowledge of the pharmacological effects associated with cannabinoid 
receptors and their agonists led the chemists to find selective analogs of THC that 
separate the beneficial effects for the treatment of some diseases. The first analogs 
discovered, also classical cannabinoids, closely related structurally with THC, were the 
HU-210 and the Nabilone. This last one was approved by the FDA for the treatment of 
nausea and vomiting in chemotherapy-induced patients. The non-classical 
cannabinoids appear later, included the CP series developed by Pfizer and the 
aminoalkylindole series developed by Sterling Winthrop. Recently, the series JWH, 
above mentioned, were synthesized with a variety of core ring structures. These 
cannabinoid analogues were used with medicinal purposes (Kennedy). 
The synthetic cannabinoid receptor agonist may, in this way, inhibit tumor 
growth and metastasis of breast cancer and human tumor prostate PC-3 cell growth 
and interact with chemokine receptor agonists CXCR4 in modulating breast cancer 
growth and invasion. They can also affect basic neural cell processes like cell 
proliferation and survival, by the presence of CB2 receptors in neurons and glial cells in 
the brain (Seely et al. 2012). 
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1.2.4 Physiology, pharmacology and 
toxicology 
 
Almost nothing about pharmacology, toxicology and safety profile of the 
synthetic cannabinoids is known. Some studies concluded that they are responsible for 
psychiatric complications and overdose symptoms may occur, depending on the 
quantity of cannabinoids added to the mixture (AgilentTechnologies 2012) Adverse 
reactions and toxic effects result principally from activation of central CB receptors and 
β2 adrenergic receptors (Aoun et al. 2014). 
 The pharmacological effects are similar than those obtained with cannabis 
consumption, described as well-being and euphoria, sensory changes, visual, tactile 
and auditory perceptions, perceptual illusions, hallucinations and feeling of slowed 
time. Some studies showed that synthetic cannabinoids have serotonin-like or weak 
monoamine oxidase inhibitor properties (Rosenbaum et al. 2012). Their 
pharmacological activity is related with changes in the neurotransmitter system, 
intensifying the dopaminergic and catecholaminergic systems activity, inhibiting the 
reuptake of serotonin. It causes psychological and physical agitation, 
euphoria/dysphoria, impaired appetite and increased concentration (Zukiewicz-
Sobczak et al. 2012). 
The most common administration Spice intake is the inhalation. The users 
described the effects similar to those obtained with marijuana consume. The adverse 
clinical effects are mainly anxiety, paranoia, headache, nausea, vomiting, convulsions 
and inducing psychosis. They can be classified into central, cardiovascular and 
gastrointestinal effects (Cottencin et al. 2014).  
The central effects (Table 3) include emotional alterations or, in some cases of 
vulnerable individuals, psychosis. There were also described seizure activity, cognitive 
impairment, sedation, confusion and impaired motor coordination difficulties. The 
adverse physic effects include anxiety, agitation and irritability. The cardiovascular 
effects (Table 4) are tachycardia, tachyarrhythmia, cardiotoxicity, myocardial infarction 
and chest pain. Gastrointestinal effects (Table 5) such as nausea associated with 
16 
 
agitation, tachycardia, drowsiness, vomiting and hallucinations were reported. Other 
effects (Table 6) described were dilated pupils, somnolence, brisk reflexes, emesis, 
increased pulse rates and blood pressure, hyperreflexia, flushed skin and appetite 
changes (Cottencin et al. 2014). 
There is no information about chronic effects of synthetic cannabinoids; 
however, some authors referred some possible effects of the prolonged use of these 
substances as significant alterations in emotional processing and cognitive functioning. 
Other authors speculate that the long-term effects could be as the same of the 
prolonged marijuana consume, as the reduction of brain volume, affecting amygdala 
and hippocampus, which are associated with memory and the pathophysiology of 
schizophrenia and emotional processing. Some case reports focus symptoms related to 
auditory and visual hallucinations, paranoid delusions, thought blocking, disorganized 
speech, anxiety and insomnia, stupor and suicidal ideas resulting in an increased risk of 
psychosis, an age-and-dose-dependent manner (Seely et al. 2012). 
In other hand, cannabinoids can modulate pre frontal cortex neural functioning 
by decreasing the release of GABA and increasing extracellular glutamate and 
dopamine levels what results in alterations in emotional processing and cognitive 
functioning (Seely et al. 2012). 
Some case reports described the symptoms of overdoses as loss of contact and 
consciousness, seizures, aphasia, tachycardia and hallucinations followed by 
drowsiness and impaired memory. Disorientation, insomnia, memory loss and lapses, 
jerky movements and problems with speech were present even after several days 
(Adamowicz et al. 2013). Vascular reactivity and dysfunctioning have been associated 
to intoxication symptoms, especially in patients with history of ischemic heart disease 
(Aoun et al. 2014).  
In the tables present below are shown the most common effects induced by 
the consumption of synthetic cannabinoids based in case reports 
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Table 3: Central effects of synthetic cannabinoids based in case reports (Font: (Seely, Lapoint 
et al. 2012)) 
 
Central effects 
 
 
 
Psychosis 
Acute exacerbation of cannabis-induced 
recurrent psychotic episodes (Müller et al., 
2010) 
Enhanced risk of psychosis relapse in 
vulnerable individuals (Every-Palmer, 2010, 
2011) 
New-onset psychosis in otherwise healthy 
young men (Hurst et al., 2011) 
 
 
Seizures 
Seizure activity approximately 1 h after 
smoking “SpicyXXX” (Simmons et al., 2011a,b) 
Generalized seizure in a healthy 48 years old 
man within 30 min after ingesting a spice 
mixture purchased from the Internet (Lapoint 
et al., 2011) 
Witnessed generalized convulsions (Schneir 
and Baumbacher, 2012) 
 
 
Anxiety 
Occurrence of anxiety shortly after smoking 
“Banana Cream Nuke” (Schneir et al., 2011) 
Frequent anxiety in 15–19 years old boys 
consuming synthetic cannabinoids (Castellanos 
et al., 2011) 
Self-reports of users experiencing anxiety after 
injection of “Aroma” (Every-Palmer, 2010, 
2011) 
 
Agitation 
Reported to Texas poison centers by 20–23 
years old patients following exposure to 
synthetic cannabinoids Forrester et al. (2011) 
 
Irritability 
Reported to South Miami Hospital Addiction 
Treatment Center by 15–19 years old 
individuals who smoked Spice or K2 
(Castellanos et al., 2011) 
 
Memory changes 
Reported by all smokers evaluated at the South 
Miami Hospital Addiction Treatment Center 
(Castellanos et al., 2011) 
 
Sedation 
Detected in a 21 years old man an unknown 
time after smoking spice (Simmons et al., 
2011a,b) 
 
Confusion 
Detected in a 27 years old man 1 h after 
smoking SpicyXXX (Simmons et al., 2011a,b) 
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Table 4: Cardiovascular effects of synthetic cannabinoids based in case reports (Font: (Seely, 
Lapoint et al. 2012)) 
 
Cardiovascular effects 
 
 
Tachycardia 
A common clinical feature in 21–27 years old 
patients smoking SpicyXXX and other spice 
products (Forrester et al., 2011; Simmons et al., 
2011a,b) 
 
Tachyarrhytmia 
Detected in a healthy 48 years old man 30 min 
after ingesting an ethanol mixture containing a 
white powder he purchased from the Internet 
(Lapoint et al., 2011) 
 
Cardiotoxicity 
Chest pain, tachycardia, and bradycardia 
occurred in a 17 years old boy after smoking K9 
(Young et al., 2011) 
 
Chest pain 
Three 16 years old boys complained of chest 
pain within days after using K2 (Mir et al., 
2011) 
 
 
Table 5: Gastrointestinal effects of synthetic cannabinoids based in case reports (Font: (Seely, 
Lapoint et al. 2012)) 
 
Gastrointestinal effects 
 
Nausea 
Along with agitation, tachycardia, drowsiness, 
vomiting, and hallucinations, nausea was 
frequently reported after synthetic cannabinoid 
exposure (Forrester et al., 2011) 
 
Vomiting 
Described in a 19 years old healthy boy along 
with a generalized 1–2 min convulsion while 
smoking “Happy Tiger Incense” (Schneir and 
Baumbacher, 
2012) 
 
Table 6: Other effects of synthetic cannabinoids based in case reports (Font: (Seely, Lapoint et 
al. 2012)) 
 
Other effects 
 
Somnolence; dilated pupils; brisk reflexes; 
emesis. 
All common clinical features in 21–27 years old 
patients smoking SpicyXXX (Simmons et al., 
2011a,b) 
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Appetite changes 
Opposite changes have been reported, patients 
reporting both decreased and increased 
appetite (Castellanos et al., 2011) 
 
 
 
Tolerance; withdrawal and drug 
dependence 
Tolerance developed in a 20 years old boy after 
smoking “Spice Gold” daily for 8 months; during 
abstinence, he reported inner unrest, craving, 
nocturnal nightmares, copious sweating, 
headache, 
nausea, and tremor (Zimmermann et al., 2009) 
 
 
 
1.2.5 Treatment 
 
There are no specific guidelines or recognized antidotes for the treatment of 
acute synthetic cannabinoids intoxication. It is generally supportive and dependent 
upon a patient specific presentation. They were related some interventions like 
intravenous benzodiazepines administration for agitation and anxiety (Aoun et al. 
2014). 
However, there are some procedures that the patient should take when 
exposed to this kind of substances. Primarily, the consumer(s) should go immediately 
to health services or call to a poison control center. The professional must certificate 
that the vital signs, vomiting and psychiatric derangements are stabilized before 
leaving the patient (Rosenbaum et al. 2012). 
 
1.2.6 Analysis 
 
To monitor the abuse of the clandestine compounds, the forensic toxicologists 
have adopted a strategy based on two analytical steps: a preliminary screening to 
identify all the “presumptive positives” followed by a confirmation test able to identify  
the “true positives” (Favretto et al. 2013), however, analytical laboratories had 
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difficulties to obtain pure reference material for use as positive identification 
(AgilentTechnologies 2012). 
These compounds are extremely potent in terms of dosage, so usually they are 
present at trace levels. This needs the ability to analyze the complex chromatographic 
data in the presence of a large quantity of co-extractant material. These materials are 
structurally similar in chromatographic retention time and mass spectral appearance. 
Data analysis should be prepared to detect these substances in complex mixtures 
(AgilentTechnologies 2012). 
 
 
 
1.2.6.1 SCREENING METHODS 
 
Although synthetic cannabinoids were recognized by the users as legal 
alternatives to marijuana, they are not detected by traditional marijuana screening 
methods. A preliminary, high throughput analysis leads to the identification of a 
limited number of classes of compounds, such as cannabinoids, cocaine, 
amphetamines, opiates and phencyclidine, methadone, barbiturates, benzodiazepines 
and ecstasy (MDMA) (Favretto et al. 2013). Some commercial screening tests for 
synthetic cannabinoids detection for 72 hours after the consumption are commercially 
available The first one is an enzyme linked immunoabsorbent assay (ELISA) that allows 
the detection of metabolites in urine. Commercial kits for high-throughput screening 
become available too (De Brabanter 2013).  
Immunoassays specificity depends on the affinity and the cross reactivity of the 
used of antibodies for the parent drug, its analogs and its metabolites. Recently, the 
techniques based on liquid chromatography coupled to triple quadrupoles or to ion 
trap mass spectrometers allowed the diffusion of the chromatographic methods also in 
screening steps (Favretto et al. 2013). 
Recognition implies the match of the retention time and the product ion 
spectrum of the unknown analyte with the reference in databases or libraries. The 
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identification of the analytes which are not present in these libraries, as the case of the 
most recent NPSs, cannot be done. The purpose of the screening step is the 
identification of all the presumptively “positive” samples, making the possibility of 
losing “positives” cases particularly relevant (Favretto et al. 2013).  
Therefore, is important to underline that after a positive result of a screening 
test, it must be confirmed by a confirmation selective method. 
 
 
1.2.6.2 CONFIRMATION METHODS 
 
A confirmation step is generally applied to samples that were screened 
presumptively positive. The analysis must be based on a highly specific technology, 
such as classically gas chromatography or liquid chromatography coupled to mass 
spectrometry or multiple mass spectrometry when the screening is the immunoassay. 
The use of this type of technology is not required to have a high sample throughput of 
the screening, but to provide accurate recognition and in the majority of the cases the 
quantification of the target compounds (Favretto et al. 2013).  
In this case, herbal material need to be extracted and posteriorly analyzed with 
a chromatographic technique combined with mass spectrometric detection. 
Subsequently, the chromatograms are compared with a database containing known 
synthetic cannabinoids. Also can be applied the high resolution mass spectrometry or 
nuclear magnetic resonance to confirm results (De Brabanter 2013).   
Some authors demonstrate that gas chromatography-mass spectrophotometry 
(GC-MS) and liquid chromatography-mass spectrophotometry (LC-MS) can be used as 
identification and quantification techniques, although the LC-MS is the preferred one 
(Choi et al. 2013). Recently the matrix-assisted laser desorption/ionization-time of 
flight mass spectrometry (MALDI-TOF) technique has been developed and became able 
to detect synthetic cannabinoids and their metabolites in urine (Aoun et al. 2014). 
 Synthetic cannabinoids can be detected by liquid chromatography method in 
biologic samples, namely serum and whole blood (De Brabanter 2013). Because of a 
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short detection window, blood samples are used only in cases of acute intoxication. 
(Favretto et al. 2013). The detection of cannabinoids in oral fluid (saliva) can only be 
done a few hours after the consumption (Adamowicz et al. 2013). Hair can only be 
used for chronic abuses, having a poor sensitivity in cases of fresh or intermittent 
consume (Favretto et al. 2013). 
To detect metabolites present in urine matrix, an enzymatic hydrolysis is 
performed, followed by an extraction. After that, the sample is ready to be analyzed by 
LC-MS. The detection of metabolites in urine is possible until 3 weeks after the 
administration (Johnson et al. 2013). However, it is clear that using urine as matrix 
could be hardly detectable because of the complex metabolism of the synthetic 
cannabinoids (Favretto et al. 2013). 
Another technique recently developed is the DART – Direct Analysis in Real 
Time. This method requires minimal sample preparation and allows the identification 
of compounds without the use of a database. No solvents and extractions are required 
and the results are obtained in seconds. The result is a simple spectrum represented 
by the plots of the molecular ion of each detected specie versus their relative 
abundance (Musah et al. 2012). 
Although the chromatographic techniques are more specific and sensible, 
immunochemical-based detection is preferred, because is cheaper and faster (Seely et 
al. 2012).  
All of these techniques are endowed with specificity, accuracy, sensitivity, and 
precision requirements posed by forensic laboratories. They can detect the intended 
compounds even when dissimulating agents, as glycerine or fatty acid amides, are 
added. These strategies require detection of low concentrations of the psychoactive 
compounds (0.1–1.0% of weight) (Seely et al. 2012). A summary of the analytical 
methodologies described in the literature is shown in the table 7. 
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Analytes Matrix LLOQ Sample 
preparation 
GC column LC column MS 
JWH-007, JWH-015, JWH-018, JWH-019, 
JWH-020, JWH-073, JWH-081, JWH-122, 
JWH-200, JWH-203, JWH-210, JWH-250, 
JWH-251, JWH-398, AM-694, AM-2201, 
methanandamide, RCS-4, RCS-4 ortho 
isomer, RCS-8, WIN 48,098 and WIN 
55,212-2 
Hair 0,5 pg/mg LLE  Luna Phenyl Hexyl 
(50 mm × 2 mm, 5 
_m) 
Q-trap (MRM) 
 
 
JWH-250 metabolites 
Urine and 
blood 
 LLE and SPE HP-5 MS (30 m × 0.25 
mm × 0.25 _m), DB-17 
MS (15 m × 0.25 mm 
×0.25 _m) and EVDX 5 
MS  (25 m × 0.20 mm 
× 0.22 _m) 
ProntoSIL-120-5-C8 
AQ (2.1 mm × 75 
mm) 
Q (SIM) and 
QQM (MRM) 
 
JWH-018 + JWH 073 metabolites 
Urine 1,8-6,0 
ng/ml 
Dilution  Zorbax Eclipse XDB-
C18 (150 mm ×4.6 
mm, 5 _m) 
Q-Trap (SRM) 
 
JWH-018, JWH-073, JWH-200, JWH-250, 
HU21010  
Hair 0,07-10 
pg/mg 
LLE HP-5 MS (30 m ×0.25 mm 
× 0.25 _m) and EVDX 5 
MS (25 m × 
0.20 mm × 0.22 _m) 
Zorbax XDB-C18 
(30 mm × 2.1 mm, 
1.8 _m) 
QQQ (SRM) 
 
RCS-4 
Urine 10 ng/ml Protein 
precipitation 
 Hypersil GOLD C18 LiT 
 
JWH-018 and JWH-073 metabolites 
Urine  LLE and SPE  Zorbax 80SB-C18 
(75 mm × 4.3 mm, 5 
_m) 
Q, Q-TOF and 
QQQ 
JWH-200, AM 694, 
JWH-250, JWH-073, JWH-018, JWH-019, 
JWH-122, HU 210 and CP 47, 497 
Saliva 1 ng/ml Dilution  C18 (100 mm × 2.1 
mm, 2.6 _m) 
QQQ (MRM) 
Table 7: Analytical methodologies on the chromatographic/mass spectrometric for synthetic cannabinoids analysis in biological samples (Favretto et al. 2013). 
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LLOQ: Lower limit of quantification  
JWH-018, JWH-073, JWH-398, JWH-250, 
JWH- 122, JWH-019, JWH-200 and RCS-4 
metabolites 
Urine 0,1 ng/ml LLE  AQUASIL C18 (100 
mm × 2.1 mm, 5 _m) 
QTrap 
CP 47, 497 Urine 10 ng/ml Dilution  Eclipse Plus C18 
(2.1 mm × 50 mm, 
1.8 _m) 
QQQ (MRM) 
AM-694, AM-1241, WIN 55212-2 mesylate, 
RCS-4-C-4 homolog, JWH-015, JWH-302, 
JWH-073, JWH-250, JWH-203, JWH-081, 
JWH-019, JWH-210, JWH-018, JWH-007, 
JWH-398, CP 47,497, CP 47, 497C-8 
homolog, HU-210 and JWH-251 
Blood 0,5 ng/ml LLE  Eclipse C18 
(2.1 mm × 150 mm, 
5 _m) 
QQQ (MRM) 
RCS-4 and 16 metabolites Urine  Hydrolysis LLE 
derivatization 
HP-5 MS (30 m × 0.25 
mm × 0.25 _m), VF5-MS 
(30 m × 0.25 mm × 0.25 
_m) 
 Q 
1JWH-018, JWH-073 and their omega and 
omega-1 metabolites 
Urine 0,1-0,19 
ng/ml 
Enzymatic 
hydrolysis 
SPE 
 Zorbax XDB-C18 QTrap (SRM-
IDA) 
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Although consume of synthetic cannabinoids and ∆9-THC can be compared since 
their psychoactive effects are similar, synthetic cannabinoids consume seems to be 
more harmful because their constituents are based in chemical formulations. The 
study of synthetic cannabinoids has become more explored for the scientific 
community in the last years, however, the real danger of these drugs consume is not 
really elucidated. In this way, the knowledge of the combustion products resulting of 
synthetic cannabinoids present in commercial samples bought in on-line shops proved 
to be an interesting topic to be explored since few studies in this area were realized 
until now.  
In this way, the aims of the present work are the identification and 
characterization of synthetic cannabinoids and the identification of the new products 
formed during the combustion process, it is, mimicking what happens during their 
consume by inhalation. Those objectives allow the knowledge of the toxicity of 
synthetic cannabinoids when smoked, by the development of methodologies that 
simulate the referred process. Firstly, a muffle furnace apparatus was used to heat the 
samples until their combustion temperature, in order to obtain the resulting 
compounds of the pyrolysis of synthetic cannabinoids. Since no results were obtained 
unless the decrease of their concentration, a new method needed to be developed. 
For this purpose, an apparatus allowing the simulation of the combustion process of 
the synthetic cannabinoids enabled the identification of the intended compounds. 
Those results were obtained by GC-MS analysis. 
Although the synthetic cannabinoids themselves could not present a real danger, 
the combination of the new products formed during the combustion process can be 
pernicious, as will be show during the presentation of this experimental work. 
The developed combustion technique can be used likewise to identify combustion 
products of tobacco and other drugs. 
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CHAPTER I: 
MATERIAL AND METHODS 
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1. MATERIAL 
 
 
1.1 Commercial samples 
 
Three plant sample material with 1g each one, called CM21, SHIVA 
ULTRASTRONG and SCORPION ULTRASTRONG, were obtained in an online shop 
included in herbal incenses category with the description “potpourri”. The price of 
each package was 13 euros. The characterization of these products is described below. 
 
1.1.1 HERBAL INCENSE: CM21 
 
1.1.2 HERBAL INCENSE: SCORPION ULTRASTRONG 
 CM 21 Herbal Incense is a blend of natural herbs and essential oils that 
refreshes the air with aromatic fragrance when burned. Creates an 
exotic and relaxing sensation. It is perfect to elevate your mood. Very 
nice aroma. Containing a mixture of herbal resins.  
 
Warning: 
This product is not for human consumption.  
The product should be kept out of reach of children.  
Swallowing should contact the health services responsible. 
 
 
 
 
 
 
 
 
    
Scorpion Ultra Strong Herbal Incense is a blend of natural herbs and essential oils 
that refreshes the air with aromatic fragrance when burned. Creates an exotic 
and relaxing sensation. It is perfect to elevate your mood. Very nice aroma. 
Containing a mixture of herbal resins. 
 
Warning:  
 This product is not for human consumption.  
 The product should be kept out of reach of children.  
 Swallowing should contact the health services responsible. 
 
 
 
 
 
Figure 3: Herbal 
incense CM21 sold 
in online headshops 
Figure 4: Herbal 
incense SCORPION 
ULTRASTRONG sold in 
online headshops 
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1.1.3 HERBAL INCENSE: SHIVA ULTRASTRONG 
 
 
 
 
1.2 Samples preparation 
 
 
Commercial samples were triturated with a mortar and a pestle.  
Firstly, five mg of each sample were dissolved in 1 mL of methanol. The mixture 
was homogenized in a vortex during 1 minute and centrifuged 10 minutes, filtered and 
analyzed in a GC-MS.  
Five mg of each samples were weighed and placed into an open ampoule that 
posteriorly was submitted to heating in a muffle furnace (section 2.2) in a way of being 
totally sealed, avoiding the escape of volatiles that would form upon combustion 
process. 
For combustion procedure, five mg of each sample were likewise weighted in 
triplicate and then put into the combustion tube according to the method described in 
the section 2.1 of this chapter. 
 
Shiva Ultra Strong Herbal Incense is a blend of natural herbs and essential oils that 
refreshes the air with aromatic fragrance when burned. Creates an exotic and 
relaxing sensation. It is perfect to elevate your mood. Very nice aroma. Containing a 
mixture of herbal resins. 
 
Warning:  
This product is not for human consumption.  
The product should be kept out of reach of children. 
Swallowing should contact the health services responsible. 
 
 
 
 
 
Figure 5: Herbal 
incense SHIVA 
ULTRASTRONG sold 
in online headshops. 
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1.3 Reagents and equipment 
 
 
Methanol (HPLC grade) was purchased from Fisher Chemical. Thymol was used 
as an internal standard (1mg/mL). SPE was performed using C18 Sep-Pack colum 
obtained from Waters (Milford, Massachusetts, USA) SPE Vacuum Pump from BUSHI 
LaborTechnik AG (Switzerland). The sample concentrator used to dry samples after the 
extraction from the SPE cartridge was from Barloworld Scientific Limited Stone 
(Staffordshire, UK). The vials used have the volume of 2mL and the sample containers 
for the combustion process 10mL. The syringes used to extract the volatile contained 
in the SPE cartridge were labelled BRAUN (Germany) Omnifix 1mL. The filters used to 
filter the standard samples have a 0,45µm of pore size and 25mm of diameter The 
muffle furnace Thermoline 48000 was from Barnstead/Thermoline (Kerper Boulevard, 
USA).  
 
 
1.4 GC-MS conditions 
 
 
 
 
 
 
 
 
 
 
 
Figure 6: GC-MS equipment used in this experiment. 
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GC-MS analysis was carried out using a Varian CP-3800 gas chromatograph 
(USA) equipped with a Varian Saturn 4000 Ion Trap mass selective detector (USA) and 
a Saturn GC/MS workstation software version 6.8. A capillary column VF-5ms (30 m x 
0.25 mm x 0.25 μm) from VARIAN was employed for the separation. Helium C-60 
(Gasin, Portugal), at a constant flow rate of 1 mL/min, was used as the carrier gas. The 
injection of 2 μL of samples was manually done in the splitless mode at 250 ºC. The 
column oven temperature was maintained at 100 ºC for 1 min and then raised to 300 
ºC at 15 ºC/min and hold at 300 ºC for 20 min. During the first 4 min, the ionization 
was maintained off to avoid solvent overloading. Data were collected from m/z 50-
600. The emission current was 30 μA and the maximum ionization time was 25,000 μs. 
Mass spectra acquisition was performed between 4 and 30 min after the injection of 
the sample. Full scan mode allows the detection of all ions and was used for the 
identification of compounds.  
The identification of each analyte in samples was made comparing the retention 
times (Tr) and mass spectra (relative abundance of the ions) of the same 
characteristics of the samples described in the literature and using the library swgdrug 
in the MS Data Review program. 
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2. COMBUSTION METHODOLOGIES 
 
 
2.1 Muffle furnace 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7: Muffle furnace apparatus 
 
 
A muffle furnace is similar to a kiln, introducing het electronically at extremely 
high temperatures within an insulated and enclosed area. It has an oven capable of 
reaching high temperatures with a heating chamber that is isolated from the fuel 
source and by the products created. The maximum output temperatures vary up to 
1204 degrees Celsius. It is often used in craft, industrial and scientific laboratory 
settings. In this experiment, the muffle furnace was used to lead the herbal incenses to 
their combustion temperature, which may vary from 450 to 550 degrees Celsius. Thus, 
each of the three different samples (CM21, SCORPION ULTRASTRONG and SHIVA 
ULTRASTRONG) was weighed (5mg) and put inside a glass ampoule in triplicate and 
properly sealed. After that, the glass ampoules were placed into a porcelain crucible 
and then inside of the muffle furnace. Each triplicate of the three different herbal 
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 100º
C 
  
   
   
   
   
   
samples was submitted to different temperatures: 100, 200, 300, 400, 500 and 600 
degrees Celsius for ten minutes.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8: Muffle furnace method – Schematic representation of the samples analyzed.  
CM21  
SHIVA  
CM21  
CM21  
CM21  
CM21  
CM21  
SCORPION  
SCORPION  
SCORPION  
SCORPION  
SCORPION  
SCORPION  
SHIVA  
SHIVA 
SHIVA  
SHIVA  
SHIVA  
200ºC 
300ºC 
400ºC 
500ºC 
600ºC 
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2.2 Development of an apparatus to collect volatiles  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9: Simulation of the conditions of smoke synthetic cannabinoids - Combustion method. 
(Legend: 1 – Butane/Propane stone bottle; 2 – Glass tube (sample container); 3 – Claws; 4 – 
Glass tubes; 5 –SPE cartridge; 6 – Flexible hose; 7- Vacuum system) 
 
 
In this method, the sample is pyrolyzed under conditions that mimicked those 
used by recreational drug smoking. 
Five mg of each synthetic cannabis material were weighed and after that 
transferred to a tube (“sample container”) to be combusted. Attached to this tube, 
there has another tube that, in turn, is attached to an SPE cartridge with a small piece 
of flexible hose. 
The vacuum pump is attached to the base of the SPE cartridge. The pressure of 
the vacuum system varies for 165 to 175 mbar.  
The sample was heated using a Bunsen burner.  
2 
 
 
3 
 
 
4 
 
 
7 
 
 
3 
4 
 
 
6 
 
 
5 
 
 
1 
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The vacuum and the Bunsen burner are turned on and the smoke is pulled out 
of the test tube and captured on the SPE cartridge. Combustion could clearly be seen 
when the smoke began to form inside the test tube.  
After ten minutes, the vacuum system and the Bunsen burner are turned off. 
The volatiles contained in the SPE cartridge are extracted with 2 ml of methanol with a 
syringe and 30 µL of internal standard (Thymol 1mg/mL) were added and led to 
dryness with flow nitrogen, and then resuspended in 100 µL of methanol.  
To the test tube, that contains the ashes, was added 1 mL of methanol and 50 
µL of internal standard (Thymol 1mg/mL). The tube is vortexed for two minutes and 
the mixture was put in a vial. Then, the sample was filtered and placed in a storage 
vial. All this procedure is done in triplicate. 
The samples were injected in the GC/MS and analyzed. 
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1. SAMPLES ANALYSIS  
 
 
1.1 Herbal incense: CM21 
 
   
Figure 10: CM21 chromatogram (5mg of the sample dissolved in 1mL of methanol and filtered) 
and the main synthetic cannabinoids peaks found.
 
 
 
3 
 
 
1 
 
 
2 
 
 
4 
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(swgdrug) AM2201 2'-naphthyl isomer
388 408 428 448 468 488 508
25
56
87
O
N
F
(Text File) 18.682 min, Scan: 1610
50 150 250 350 450 550
0
50
100
144
232
284
359 501
(swgdrug) JWH-122 N-(4-pentenyl) analog
50 60 70 80 90 100 110
28
61
94
N
O
(Text File) 18.895 min, Scan: 1630
50 110 170 230 290 350
0
50
100
89
115
141
169
212
254 298 353
(swgdrug) MAM2201 N-(4-fluoropentyl) isomer
305 315 325 335 345 355 365 375
51
72
93
N
O
F
(swgdrug) MAM2201 N-(4-fluoropentyl) isomer
309 319 329 339 349 359 369 379 389
51
74
97
N
O
F
(Text File) 20.456 min, Scan: 1777
50 110 170 230 290 350
0
50
100
51
89
115
141
169
232
298 374
(Text File) 24.442 min, Scan: 2152
50 120 190 260 330 400
0
50
100
89
115
169
248 298
372
Table 8: CM21 herbal incense interesting peaks identification by the library swgdrug.
Peak 
number 
Retention 
time 
   m/z                    Mass spectrum Library 
identification 
% of probability by 
swgdrug library 
Molecular structure 
 
1 
 
18,669 
 
144, 232, 284, 
359 
  
AM2201 2'-
naphthyl isomer 
 
 
34,4% 
 
 
 
2 
 
18,897 
 
115, 141, 169, 
212, 298, 353 
  
JWH-122 N-(4-
pentenyl) analog 
 
57,4% 
 
 
 
3 
 
20,460 
89, 115, 141, 
139, 232, 298, 
374 
 
 
 
MAM2201 N-(4-
fluoropentyl) 
isomer 
 
50,3% 
 
 
 
4 
 
24,450 
 
89, 115, 169, 
248, 298, 372 
 
 
 
MAM2201 N-(4-
fluoropentyl) 
isomer 
 
 
34,3% 
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1.2 Herbal incense: SCORPION ULTRASTRONG 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 11: SCORPION ULTRASTRONG chromatogram (5mg of the sample dissolved in 1mL of 
methanol and filtered) and the main synthetic cannabinoids peaks found. 
 
 
1 
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(Text File) 19.004 min, Scan: 1634
50 150 250 350 450 550
0
50
100
115
144
169
214
298
340 545
(swgdrug) JWH-122 7-methylnaphthyl isomer
358 388 418 448 478 508
25
56
87
O
N
Table 9: SCORPION ULTRASTRONG herbal incense interesting peaks identification by the library swgdrug. 
 
 
Peak 
number 
Retention time m/z Mass spectrum Library identification % of probability by 
swgdrug library 
Molecular structure 
 
 
1 
 
 
19,004 
 
 
115, 144, 
169, 214, 
298, 340 
  
 
JWH-122 7-
methylnaphthyl isomer 
 
 
18,5% 
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2 
1.3 Herbal incense: SHIVA ULTRASTRONG 
 
 
 
Figure 12: SHIVA ULTRASTRONG chromatogram (5mg of the sample dissolved in 1mL of 
methanol and filtered) and the main synthetic cannabinoids peaks found.
3 
1 
4 
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(swgdrug) JWH-122 N-(4-pentenyl) analog
50 60 70 80 90 100 110
28
61
94
N
O
(Text File) 20.456 min, Scan: 1777
50 110 170 230 290 350
0
50
100
51
89
115
141
169
232
298 374
(swgdrug) AM2201
50 80 110 140 170 200
41
70
99
N
O
F
(swgdrug) MAM2201
75 95 115 135 155 175
48
74
100
N
O
F
(Text File) 19.101 min, Scan: 1575
50 130 210 290 370 450
0
50
100
144
232
284
359
401 477
(Text File) 19.348 min, Scan: 1598
50 150 250 350 450 550
0
50
100
115
141
169
212
298
353
441488 549
Table 10: SHIVA ULTRASTRONG herbal incense interesting peaks identification by the library swgdrug. 
Peak 
number 
Retention time 
(min.) 
m/z Mass spectrum Library 
identification 
% of probability by 
swgdrug library 
Molecular structure 
 
 
1 
 
 
19,101 
 
 
144, 232, 284, 
359 
 
 
 
AM2201  
 
 
 
68,0% 
 
 
 
2 
 
 
19,348 
 
115, 141, 169, 
212, 298, 353 
 
 
 
JWH-122 N-(4-
pentenyl) analog 
 
 
88,6% 
 
 
 
3 
 
 
21,044 
 
115, 169, 232, 
255, 284, 298, 
313, 374 
 
 
 
MAM2201  
 
73,9% 
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(swgdrug) MAM2201 N-(5-chloropentyl) analog
440 470 500 530 560 590
30
59
88
N
O
Cl
 
4 
 
25,146 
 
115, 169, 248, 
298, 389 
 
 
 
 
MAM2201 N-(5-
chloropentyl) 
analog 
 
 
96,9 % 
 
(Text File) 25.146 min, Scan: 2134
50 160 270 380 490 600
0
50
100
115
169 248
298
389
414463 535595
50 
 
(swgdrug) MAM2201 N-(4-fluoropentyl) isomer
50 140 230 320 410 500
0
50
100
141
169
232
254
298
373 N
O
F
(swgdrug) JWH-122 N-(4-pentenyl) analog
50 140 230 320 410 500
0
50
100
141
169
212 298
353
N
O
2. SYNTHETIC CANNABINOIDS CHARACTERIZATION 
 
2.1 Synthetic cannabinoids present in the CM21 sample  
 
MAM2201 N-(4-fluoropentyl) isomer (SYNTHETIC CANNABINOID 1) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 13: MAM2201 N-(4-fluoropentyl) isomer ion spectrum from the library swgdrug. 
 
 
JWH-122 N-(4-pentenyl) analog (SYNTHETIC CANNABINOID 2) 
 
 
 
 
 
 
 
 
 
Figure 14: JWH-122 N-(4-pentenyl) analog ion spectrum from the library swgdrug. 
Name: MAM2201 N-(4-fluoropentyl) isomer 
Formula: C25H24FNO 
MW: 373 ID#: 3299 DB: swgdrug 
Comment: Provided by 
www.caymanchem.com/app/template/landing%2CForensic.v
m / Item #11782  Lot #0439334 
10 largest peaks:  
 232 999 | 141 847 | 115 751 | 298 718 | 144 
717 | 169 715 | 181 496 | 149 409 | 373 366 | 116 361 | 
Synonyms:  
1.(1-(4-fluoropentyl)-1H-indol-3-yl)(4-methylnaphthalen-1-
yl)methanone 
Estimated Kovats RI:  
Value: 3011 iu 
Confidence interval (Diverse functional groups):  89(50%) 
382(95%) iu 
 
 
Name: JWH-122 N-(4-pentenyl) analog 
Formula: C25H23NO 
MW: 353 ID#: 3141 DB: swgdrug 
Comment: Provided by 
www.caymanchem.com/app/template/landing%2CForensic.v
m / Item #11611  Lot #0437478 
10 largest peaks:  
169 999 | 353 677 | 212 492 | 298 478 | 141 
422 | 115 351 | 144 255 | 41 219 | 284 204 |352 202 | 
Synonyms:  
1.MAM2201 N-(4-pentenyl) analog 
2.JWH-022 4-methylnaphthyl analog 
3.(4-methylnaphthalen-1-yl)(1-(pent-4-en-1-yl)-1H-indol-3-
yl)methanone 
Estimated Kovats RI:  
Value: 3092 iu 
Confidence interval (Diverse functional groups):  89(50%) 
382(95%) iu 
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(swgdrug) AM2201 2'-naphthyl isomer
50 110 170 230 290 350
0
50
100
51
77
127
155
170
232
284
359
O
N
F
(swgdrug) JWH-122 7-methylnaphthyl isomer
50 130 210 290 370 450
0
50
100
55
144
181
214
298
355
O N
AM2201 2'-naphthyl isomer (SYNTHETIC CANNABINOID 3) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 15: AM2201 2'-naphthyl isomer ion spectrum from the library swgdrug. 
 
 
 
 
2.2 Synthetic cannabinoids present in the SCORPION 
ULTRASTRONG sample 
 
 
 
JWH-122 7-methylnaphthyl isomer (SYNTHETIC CANNABINOID 4) 
 
 
 
 
 
 
 
 
 
Figure 16: JWH-122 7-methylnaphthyl isomer ion spectrum from the library swgdrug. 
Name: AM2201 2'-naphthyl isomer 
Formula: C24H22FNO 
MW: 359 ID#: 3218 DB: swgdrug 
Comment: DEA SFL1 / Cayman lot 0430209-19 
10 largest peaks:  
359 999 | 127 986 | 232 869 | 155 597 | 284 563 | 144 480 | 
128 305 | 360 259 | 41 238 | 116 199  
Synonyms:  
1.(1-(5-fluoropentyl)-1H-indol-3-yl)(naphthalen-2-
yl)methanone 
Estimated Kovats RI:  
Value: 2962 iu 
Confidence interval (Diverse functional groups):  89(50%) 
382(95%) iu 
 
 
Name: JWH-122 7-methylnaphthyl isomer 
Formula: C25H25NO 
MW: 355 ID#: 2849 DB: swgdrug 
Comment: Provided by 
www.caymanchem.com/app/template/landing%2CForensic.v
m / Item #9001036  Lot #0431265 
10 largest peaks:  
355 999 | 214 716 | 298 645 | 181 430 | 144 
384 | 141 382 | 338 381 | 115 292 | 356 271 | 169 240 | 
Synonyms:  
1.(7-methylnaphthalen-1-yl)(1-pentyl-1H-indol-3-
yl)methanone 
Estimated Kovats RI:  
Value: 3102 iu 
Confidence interval (Diverse functional groups):  89(50%) 
382(95%) iu 
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(swgdrug) AM2201
50 120 190 260 330 400
0
50
100
50 77
127
144
232
284
342
359
N
O
F
(swgdrug) MAM2201
60 120 180 240 300 360
0
50
100
89
115
144
169
232
254
284
298
312
356
373
N
O
F
2.3 Synthetic cannabinoids present in the SHIVA 
ULTRASTRONG sample  
 
AM2201 (SYNTHETIC CANNABINOID 5) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 17: AM2201 ion spectrum acquired by the library swgdrug in GC-MS. 
 
MAM2201 (SYNTHETIC CANNABINOID 6) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 18: MAM2201 ion spectrum from the library swgdrug. 
 
 
Name: MAM2201 
Formula: C25H24FNO 
MW: 373 CAS#: 1354631-24-5 ID#: 2847 DB: swgdrug 
Other DBs: None 
Comment: Provided by 
www.caymanchem.com/app/template/landing%2CForensi
c.vm / Item #9001219  Lot #0436216 
10 largest peaks:  
373 999 | 298 585 | 356 582 | 232 555 |
 372 465  
144 366 | 115 314 | 141 310 | 284 257 |
 374 250  
Synonyms:  
1.AM2201 4-methylnaphthyl analog 
2.JWH-122 N-(5-fluoropentyl) analog 
3.[1-(5-fluoropentyl)-1H-indol-3-yl](4-methyl-1-
naphthalenyl)-methanone 
Estimated Kovats RI:  
Value: 3075 iu 
Confidence interval (Diverse functional groups):  89(50%) 
382(95%) iu 
 
 
Name: AM2201 
Formula: C24H22FNO 
MW: 359 CAS#: 335161-24-5 ID#: 2516 DB: swgdrug 
Other DBs: None 
Comment: Jason Nawyn / standard from Cayman 
Chemicals (lot # 0427135-1) 
10 largest peaks:  
359 999 | 284 519 | 232 472 | 342 447 | 358 436 | 127 314 
| 360 250 | 144 206 | 270 168 |155 150 | 
Synonyms:  
1.1-(5-fluoropentyl)-3-(1-naphthoyl)indole 
Estimated Kovats RI:  
Value: 2962 iu 
Confidence interval (Diverse functional groups):  89(50%) 
382(95%) iu 
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(swgdrug) JWH-122 N-(4-pentenyl) analog
50 140 230 320 410 500
0
50
100
141
169
212 298
353
N
O
(swgdrug) MAM2201 N-(5-chloropentyl) analog
50 150 250 350 450 550
0
50
100
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JWH-122 N-(4-pentenyl) analog (SYNTHETIC CANNABINOID 2) 
 
 
 
 
 
 
 
 
 
Figure 19: JWH-122 N-(4-pentenyl) analog ion spectrum from the library swgdrug. 
 
 
MAM2201 N-(-5-chloropentyl) analog (SYNTHETIC CANNABINOID 7) 
 
  
Name: JWH-122 N-(4-pentenyl) analog 
Formula: C25H23NO 
MW: 353 ID#: 3141 DB: swgdrug 
Comment: Provided by 
www.caymanchem.com/app/template/landing%2CForensic.v
m / Item #11611  Lot #0437478 
10 largest peaks:  
169 999 | 353 677 | 212 492 | 298 478 | 141 422 | 115 351 | 
144 255 | 41 219 | 284 204 | 352 202 Synonyms:  
1.MAM2201 N-(4-pentenyl) analog 
2.JWH-022 4-methylnaphthyl analog 
3.(4-methylnaphthalen-1-yl)(1-(pent-4-en-1-yl)-1H-indol-3-
yl)methanone 
Estimated Kovats RI:  
Value: 3092 iu 
Confidence interval (Diverse functional groups):  89(50%) 
382(95%) iu 
 
 
Name: MAM2201 N-(5-chloropentyl) analog 
Formula: C25H24ClNO 
MW: 389 CAS#: 1445578-25-5 ID#: 3469 DB: swgdrug 
Other DBs: None 
Comment: Provided by 
www.caymanchem.com/app/template/landing%2CForensic.v
m / Item #13103  Lot #0445942 
10 largest peaks: 389 999 | 298 870 | 141 723 |115 680 | 
248 590 |169 569 | 372 552 | 144 550 |388 467 | 
374 384 | 
Synonyms:  
1.JWH-122 N-(5-chloropentyl) analogue 
2.(1-(5-Chloropentyl)-1H-indol-3-yl)(4-methylnaphthalen-1-
yl)methanone 
Estimated Kovats RI:  
Value: 3327 iu 
Confidence interval (Diverse functional groups):  89(50%) 
382(95%) iu 
 
 
Figure 20: MAM2201 N-(-5-chloropentyl) analog ion spectrum from the library swgdrug. 
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3. GC/MS RESULTS – MUFFLE FURNACE  
 
 
The aim of this experiment was to search combustion products of the referred 
synthetic cannabinoids. For this purpose, samples were submitted to different 
temperatures (1000C, 2000C, 3000C, 4000C, 5000C and 6000C) according to the 
methodology described before, in order to study the decrease of the synthetic 
cannabinoids concentration and the appearance of new compounds, resulting of the 
combustion process.  
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3.1 Herbal incense: CM21 
 
Figure 21: CM21 herbal incense chromatograms analysis of the samples submitted to 100, 200, 
300, 400, 500 and 600 degrees Celsius in the muffle furnace. 
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Figure 22: CM21 herbal incense chromatograms analysis of the samples submitted to 100, 200, 
300, 400, 500 and 600 degrees Celsius in a muffle furnace (focus on the main peaks related to 
the synthetic cannabinoids). 
 
In relation to the chromatograms presented above, there are 4 main peaks 
related to the synthetic cannabinoids already described in this experiment (Chapter 2 –
Section 2): AM2201 2’-naphthyl isomer (1), JWH-122 N-(4-pentenyl) analog (2) and 
MAM2201 N-(4-fluoropentyl) isomer (3, 4). In the table are represented the respective 
peaks areas of the named synthetic cannabinoids, in order to confirm the decrease of 
the concentration with the temperature increase. 
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AM2201 2’-naphthyl isomer 
JWH-122 N-(4-pentenyl) 
analog 
MAM2201 N-(4-fluoropentyl) 
isomer 
MAM2201 N-(4-fluoropentyl) 
isomer 
Table 11: Peaks areas of the synthetic cannabinoids found in the herbal incense CM21 
submitted to different temperatures in a muffle furnace. 
 
 
 
 
Figure 23: Temperature ranging versus concentration of the synthetic cannabinoids found in 
the herbal incense CM21. 
 
 
Retention time 19,035 19,248 21,274 25,552 
Compound name AM2201 2’-
naphthyl isomer 
JWH-122 N-(4-
pentenyl) 
analog 
MAM2201 N-(4-
fluoropentyl) 
isomer 
MAM2201 N-(4-
fluoropentyl) 
isomer 
Peak area (1000C) 5,916 x 106 4,650 x 106 1,240 x 108 1,316 x 107 
Peak area (2000C) 4,094 x 106 4,129 x 106 7,406 x 107 5,932 x 106 
Peak area (3000C) 3,962 x 106 4,067 x 106 7,228 x 107 2,605 x 106 
Peak area (4000C) 307547 2,313 x 106 1,009 x 107 ______ 
Peak area (5000C) ______ 2,304 x 106 3,515 x 106 ______ 
Peak area (6000C) ______ 1,149 x 106 1,577 x 106 ______ 
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3.2 Herbal incense: SCORPION ULTRASTRONG   
 
 
Figure 24: SCORPION ULTRASTRONG herbal incense chromatograms analysis of the samples 
submitted to 100, 200, 300, 400, 500 and 600 degrees Celsius in a muffle furnace. 
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Figure 25: SCORPION ULTRASTRONG herbal incense chromatograms analysis of the samples 
submitted to 100, 200, 300, 400, 500 and 600 degrees Celsius in a muffle furnace (focus on the 
main peaks related to the synthetic cannabinoids).  
 
 
In relation to the chromatograms presented above, there has only one main 
peak related to the synthetic cannabinoids already described in this experiment 
(Chapter 2 –Section 2): JWH-122 7-methylnaphthyl isomer (1). In the table is 
represented the respective peak areas of the named synthetic cannabinoids, in order 
to confirm the decrease of the concentration with the temperature increase. 
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SCORPION ULTRASTRONG 
JWH-122 7-
methylnaphthyl isomer 
Table 12: Peaks areas of the synthetic cannabinoids found in the herbal incense SCORPION 
ULTRASTRONG at different temperatures in a muffle furnace. 
 
Retention time 
 
19,508 
Compound name 
 
JWH-122 7-methylnaphthyl isomer 
Peak area (1000C) 1,177 x 108 
Peak area (2000C) 1,111 x 108 
Peak area (3000C) 1,022 x 108 
Peak area (4000C) 2,137 x 107 
Peak area (5000C) 1,092x 107 
Peak area (6000C) 7,075 x 106 
 
 
 
 
 
 
 
 
 
 
 Figure 26: Temperature ranging versus concentration of the synthetic cannabinoids 
found in the herbal incense SCORPION ULTRASTRONG. 
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3.3 Herbal incense: SHIVA ULTRASTRONG  
 
 
 
Figure 27: SHIVA ULTRASTRONG herbal incense chromatograms analysis of the samples 
submitted to 100, 200, 300, 400, 500 and 600 degrees Celsius in the muffle furnace. 
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Figure 28: SHIVA ULTRASTRONG herbal incense chromatograms analysis of the samples 
submitted to 100, 200, 300, 400, 500 and 600 degrees Celsius in a muffle furnace (focus on the 
main peaks related to the synthetic cannabinoids). 
 
 
In relation to the chromatograms presented above, there are 4 main peaks 
related to the synthetic cannabinoids already described in this experiment (Chapter 2 –
Section 2): AM2201 (1), JWH-122 N-(4-pentenyl) analog (2) and MAM2201 (3, 4). In the 
table are represented the respective peaks areas of the named synthetic cannabinoids, 
in order to confirm the decrease of the concentration with the temperature increase. 
1 3 
4 2 
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Table 13: Peaks areas of the synthetic cannabinoids found in the herbal incense SHIVA 
ULTRASTRONG at different temperatures in muffle furnace. 
 
Retention time 18,642 18,864 20,459 25,258 
 
Compound name AM2201 JWH-122 N-(4-
pentenyl) 
analog 
MAM2201 MAM2201 
Peak area (1000C) 1,416x 106 1,881 x 106 1,993 x 107 7,857 x 106 
Peak area (2000C) 1,403 x 106 1,016 x 106 1,873 x 107 6,111 x 106 
Peak area (3000C) 523749 862040 9,882 x 106 829861 
Peak area (4000C) ______ ______ ______ ______ 
Peak area (5000C) ______ ______ ______ ______ 
Peak area (6000C) ______ ______ ______ ______ 
 
 
 
Figure 29: Temperature ranging versus concentration of the synthetic cannabinoids found in 
the herbal incense SHIVA ULTRASTRONG. 
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4. GC/MS RESULTS OBTAINED FROM THE 
APPARATUS TO COLLECT VOLATILES 
 
4.1 Herbal incense: CM21 
 
 
Figure 30: Comparison between chromatograms resulting from the injection of CM21 incense 
before (1) and after (2) the combustion. 
 
The first chromatogram presented in figure 30 corresponds to the injection of 2 
µL of the solution prepared - 5mg of the sample CM21 dissolved in 1 mL of methanol. 
This chromatogram serves as a reference to compare with the chromatograms relative 
to the simulation of the combustion of these samples, giving rise to the appearance of 
combustion products of synthetic cannabinoids present in the herbal incense. Thus, 
the second chromatogram correspond to the injection of 2 µL of the solution obtained 
after the extraction of the SPE cartridge, shown in the apparatus presented in figure 9, 
with 2 mL of methanol and subsequent drying in a nitrogen flow, and resuspended in 
100uL of methanol. Thus, it is possible to observe that after being subjected to 
heating, the sample undergoes several processes of transformation, leading to the 
formation of new products, as we will verify later, on a closer examination of the 
chromatogram in question. 
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4.1.1 Volatile contained in the SPE cartridge – analysis of the 
possible combustion products 
 
 
 
 
Figure 31: Chromatogram analysis of the injection of CM21 after the combustion and the main 
peaks found related to the combustion of the synthetic cannabinoids. 
 
In the chromatogram present in figure 31 is possible to verify that, after the 
heating, there are a lot of new substances formed. The main peaks found in this 
chromatogram are: peak 1, with the retention time 5,832 minutes; peak 2, whose 
retention time is 6,873 minutes; peak 3, with retention time 7,588 minutes; The peak 4 
has a retention time of 11,340 minutes; peak 5, that appears at 11,457 minutes; peak 6 
whose retention time is 17,561 minutes; peak 7 appearing at 18,665 minutes; peak 8, 
at 18,905 minutes; peak 9 appears at 20,469 minutes and finally the peak 10 at 24,451 
minutes. Some of these peaks have an especial interest because of the coincidence of 
their m/z ratio with the m/z ratio of the molecules formed when theoretical breaks in 
the synthetic cannabinoid are simulated. 
In table 14, the main peaks are referred along with the synthetic cannabinoids 
precursors. The m/z ratio of the new founded compound is taken into account to be 
compared with the m/z ratio resultant of the breaks of the synthetic cannabinoid(s) 
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(figure 32). Moreover, it is represented in the table the identification of the 
compounds by the swgdrug library. 
Table 14: CM21 herbal incense analysis of the volatile contained in the SPE cartridge: main 
peaks founded and possible combustion products. 
 
 
Peak 
number 
 
Retention 
time 
 
m/z of the 
unknown 
compound 
 
Synthetic cannabinoid(s) that possibly 
originate this compound 
 
1 
 
5,832 
 
89, 117, 145, 
169 
 
MAM2201 N-(4-fluoropentyl) isomer or 
AM2201 2’-naphtyl isomer 
 
2 
 
6,873 
55, 69, 83, 101, 
111, 129, 143, 
215 
 
MAM2201 N-(4-fluoropentyl) isomer or JWH-
122 N-(4-fluoropentyl) isomer 
 
3 
 
7,588 
 
55, 83, 99, 
155,173, 217 
 
AM2201 2’-naphthyl isomer 
 
4 
 
11,340 
 
89, 113, 157, 
255, 326 
 
MAM2201 N-(4-fluoropentyl) isomer or 
AM2201 2’-naphtyl isomer 
 
5 
 
11,457 
 
75, 89, 113 
 
MAM2201 N-(4-fluoropentyl) isomer or 
AM2201 2’-naphtyl isomer 
 
6 
 
17,561 
 
63, 115, 144, 
169, 268, 355 
 
 
MAM2201 N-(4-fluoropentyl) isomer or 
AM2201 2’-naphtyl isomer 
 
7 
 
18,665 
 
127, 144, 232, 
256, 284, 342 
 
MAM2201 N-(4-fluoropentyl) isomer; AM2201 
2’-naphtyl isomer or  JWH-122 N-(4-
fluoropentyl) isomer 
 
8 
 
 
18,905 
 
89, 115, 141, 
169, 212, 254, 
298, 353 
 
MAM2201 N-(4-fluoropentyl) isomer or JWH-
122 N-(4-fluoropentyl) isomer 
 
9 
 
 
20,469 
 
115, 141, 169, 
232, 254, 298, 
374 
 
MAM2201 N-(4-fluoropentyl) isomer 
 
10 
 
24,451 
 
115, 144, 248, 
298, 372 
 
AM2201 2’-naphtyl isomer 
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4.1.1.1 MAM2201 N-(4-fluoropentyl) isomer (SYNTHETIC 
CANNABINOID 1) 
 
Simulations of breaks in the molecule (theoretical approach) – 
Identification of combustion products 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 32: Simulations of breaks in the molecule MAM2201 N-(4-fluoropentyl) isomer that 
could occur when the combustion process. 
 
               Each number refers to a simulation of a break in the initial molecule of the 
synthetic cannabinoid MAM2201 N-(4-fluoropentyl) isomer (figure 32). In table 15 it is 
represented the molecular weight as a result of the referred break and the 
correspondent molecular formulation. 
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Table 15: Resulting compounds of the simulation of breaks in the molecule MAM2201 N-(4-
fluoropentyl) isomer that could occur when the combustion process. 
 
Break number Resulting molecule 
(1) 
Molecular weight 
(1) 
Resulting 
molecule (2) 
Molecular 
weight (2) 
1 C24H21FNO
● 
 
358,16 CH3
● 15,02 
2 C25H24NO
● 
 
354,19 F● 19,00 
3 C23H20NO
● 
 
326,15 C2H4F
● 47,03 
4 C22H18NO
● 312,14 C3H6F
● 
 
61,05 
5 C21H16NO
● 
 
298,12 C4H8F
● 75,06 
6 C20H14NO
● 
 
284,11 C5H10F
● 89,08 
7 
 
C13H15FN
● 204,12 C12H9O
● 169,07 
8 C14H15FNO
● 
 
232,11 C11H9 
● 141,07 
9 C24H21FNO
● 
 
358,16 CH3
● 15,02 
 
  
 In each assay it was obtained a chromatogram with the peaks that allows the 
study of the combustion products of the synthetic cannabinoids presents in the drugs 
used in this experiment.  
 The peaks represented are those whose m/z ratio is coincident to the m/z 
ratio of some molecule resultant of the break of the initial molecule. In this way, the 
resultant molecule could possibly be a combustion product of the initial molecule, the 
synthetic cannabinoid. Thus, the peaks 1, 4, 5 and 6 of the chromatogram presented in 
the Figure 31 are referent to a compound that have an m/z ratio (89.1) that can 
probably be a result of the break 6 of the synthetic cannabinoid (Figure 32). The 
compound corresponding to the peak 5 has in their mass spectrum another interesting 
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m/z (75.1) meaning that this compound could be a result from the break 5 of the 
synthetic cannabinoid. On the other hand, the peak 7 refers to a molecule with two 
interesting m/z ratio, 232.1 and 284.1, meaning that it could be a resulting compound 
of the breaks 8 or 6 of the synthetic cannabinoid, respectively. The peak 8 correspond 
to a molecule that has also a special interest because of their m/z ratio (141.1 and 
169.1) that could be a result of the breaks 8 and 7, respectively. The peak 9 is 
correspondent to a compound with two interesting m/z ratios (169.1 and 232.1) that 
could be a resulting compound from the breaks 7 and 8 of the initial molecule. Finally, 
the peak 10 is referent to a molecule that has a m/z ration of 169.1 meaning that it 
could be a result of the break 7. 
 
Table 16: Possible resulting compounds of the combustion of the synthetic cannabinoid 
MAM2201 N-(4-fluoropentyl) isomer present in CM21 blends. 
 
 
Peak number Retention time 
(minutes) 
Interesting m/z Break (number) 
1 5,382 89,1 6 
4 11,340 89,1 6 
5 11,457 75,1 5 
5 11,457 89,1 6 
6 17,561 89,1 6 
7 18,665 232,1 8 
7 18,665 284,1 6 
8 18,905 169,1 7 
8 18,905 141,1 8 
9 20,469 169,1 7 
9 20,469 232,1 8 
10 24,451 169,1 7 
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Combustion products 
 
After an extensive analysis of the results obtained, molecules that could 
possibly be combustion products of the synthetic cannabinoid MAM2201 N-(4-
fluoropentyl) isomer are represented in the table 17. These results were obtained 
comparing the molecular weight of the resultant molecules obtained by the simulation 
of the breaks in the synthetic cannabinoid (theoretical approach) with the molecular 
weight of the identified compound in the resultant chromatogram of the combustion 
experiment.  
 
Table 17: Compounds resulting of the matching  between the simulation of the breaks 
(theoretical approach) in the molecule of the synthetic cannabinoid MAM2201 N-(4-
fluoropentyl) isomer and the compounds found in the chromatograms resulting of the 
combustion assay of the compound CM21. 
 
 
 
C4H9F 
 
 
2-fluorobutane 
 
 
 
 
C5H11F  
 
 
2-fluoropentane 
 
 
 
 
C20H15NO 
 
 
 
(1h-inden-2-yl)(4-
methylnaphthalen-1-yl)methano 
 
 
 
 
 
 
 
C12H10O 
 
 
4-methyl-1-naphtaldehyde 
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C14H16FNO 
 
 
1-(4-fluoropentyl)-3-methyl-1H-
indole 
 
 
 
 
 
 
C11H10  
 
 
1-methylnaphtalene 
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4.1.1.2 JWH-122 N-(4-pentenyl) analog (SYNTHETIC CANNABINOID 2) 
 
Simulations of breaks in the molecule – Identification of combustion 
products – Theoretical approach 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 33: Simulations of breaks in the molecule JWH-122 N-(4-pentenyl) analog that could 
occur when the combustion process. 
 
 Each number refers to a simulation of a break in the initial molecule of the 
synthetic cannabinoid JWH-122 N-(4-pentenyl) analog. In table 18 is represented the 
molecular weight as a result of the referred break and the correspondent molecular 
formulation. 
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Table 18: Resulting compounds of the simulation of breaks in the molecule JWH-122 N-(4-
pentenyl) analog that could occur when the combustion process. 
 
Break number Resulting molecule 
(1) 
Molecular 
weight (1) 
Resulting 
molecule (2) 
Molecular 
weight (2) 
1 C24H23NO 
 
341,18 CH2 14,02 
2 C23H20NO
● 
 
326,15 C2H3
● 27,02 
3 C22H18NO
● 
 
312,14 C3H5
● 41,04 
4 C21H16NOv 299,13 C4H7
● 19,00 
 
5 C20H14NO 
 
284,11 C5H9
● 69,07 
6 C13H14N
● 
 
184,11 C12H10O
● 169,07 
7 C14H14NO
● 
 
212,11 C11H9
● 141,07 
8 C24H20NO
● 
 
338,15 CH3 15,02 
 
 
 In each assay it was obtained a chromatogram with the peaks that allows the 
study of the combustion products of the synthetic cannabinoids presents in the drugs 
used in this experiment.  
 The peaks represented are those corresponding to compounds whose m/z 
ratio is coincident to the m/z ratio of some molecule resultant of the break of the 
initial molecule. In this way, the resultant molecule could possibly be a combustion 
product of the initial molecule, the synthetic cannabinoid. Thus, the peaks 2 and 4 of 
the chromatogram presented in the Figure 31 has a chromatographic peak 
corresponding to a compound having a m/z ratio (55.2) that can probably be a result of 
the break 4 of the synthetic cannabinoid (Figure 33). Also chromatographic peaks 6 
and 7 correspond to molecules having in their mass spectrum fragmentation with a 
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m/z (284.1) that could be a result of the break 5 of the synthetic cannabinoid. The 
chromatographic peaks 8, 9 and 10 correspond to a compound with a m/z ratio of 
169.1, meaning that it could result from the break 6 of the synthetic cannabinoid. The 
peak 8 corresponds to a molecule with a m/z ratio of 141.1 that could be result of the 
break 7. 
 
Table 19: Possible resulting compounds of the combustion of the synthetic cannabinoid JWH-
122 N-(4-pentenyl) analog present in CM21 blends. 
 
 
Combustion products 
 
After an extensive analysis of the results obtained, molecules that could 
possibly be combustion products of the synthetic cannabinoid JWH-122 N-(4-pentenyl) 
analog are presented in the table 20. This result was obtained comparing the 
molecular weight of the resultant molecules obtained by the simulation of the breaks 
in the synthetic cannabinoid with the molecular weight of the identified compound in 
the resultant chromatogram of the combustion experiment.  
 
Table 20: Compounds resulting of the matching  between the simulation of the breaks 
(theoretical approach) in the molecule of the synthetic cannabinoid JWH-122 N-(4-pentenyl) 
Peak number Retention time 
(minutes) 
Interesting peak Break (number) 
2 6,873 55,2 4 
4 11,032 55,2 4 
6 17,561 284,1 5 
7 18,665 284,1 5 
8 18,905 169,1 6 
8 18,905 141,1 7 
9 20,448 169,1 6 
10 24,451 169,1 6 
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analog and the compounds found in the chromatograms resulting of the combustion assay of 
the compound CM21. 
 
 
 
 
C20H14NO 
 
 
 
3-(1-(4-methylnaphthalen-1-
yl)vinyl)-1-(pent-4-en-1-
yl)indoline 
 
 
 
 
 
C4H8 
 
but-1-ene 
 
 
 
C12H10O 
 
4-methyl-1-naphtaldehyde 
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4.1.1.3 AM2201 2’-naphthyl isomer (SYNTHETIC CANNABINOID 3) 
 
Simulations of breaks in the molecule (theoretical approach) – 
Identification of combustion products 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 34: Simulations of breaks in the molecule AM2201 2’-naphthyl isomer that could occur 
when the combustion process. 
 
 Each number refers to a simulation of a break in the initial molecule of the 
synthetic cannabinoid AM2201 2’-naphthyl isomer. In table 21 it is represented the 
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molecular weight as a result of the referred break and the correspondent molecular 
formulation. 
 
Table 21: Resulting compounds of the simulation of breaks in the molecule AM2201 2’-
naphthyl isomer that could occur when the combustion process. 
 
Break number Resulting 
molecule (1) 
Molecular weight 
(1) 
Resulting 
molecule (2) 
Molecular weight 
(2) 
1 C24H22NO
● 
 
340,17 F 19,00 
2 C23H20NO
● 
 
326,15 CH2F
● 33,01 
3 C22H18NO
● 
 
312,14 C2H4 F
● 47,03 
4 C21H16NO
● 299,13 C4H8F
● 75,06 
 
5 C3H6F
● 
 
61,05 C20H14NO
● 284,11 
6 C19H12NO
● 270,09 C5H10F
● 89,08 
 
7 C13H15FN
● 
 
204,12 C11H7O
● 155,05 
8 C14H15FNO
● 
 
232,11 C10H7
● 127,05 
 
 
 In each assay it was obtained a chromatogram with the peaks that allows the 
study of the combustion products of the synthetic cannabinoids presents in the drugs 
used in this experiment.  
 The peaks represented are those corresponding to compounds whose 
compounds m/z ratio is coincident to the m/z ratio of some molecule resultant of the 
break of the initial molecule. In this way, the resultant molecule could possibly be a 
combustion product of the initial molecule, the synthetic cannabinoid. Thus, the peaks 
1, 3, 4 and 5 of the chromatogram presented in the Figure 31 are referent to 
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compounds with a common m/z ratio (89.1) that can probably be a result of the break 
6 of the synthetic cannabinoid (Figure 34). Also the peak 3 is correspondent to 
molecules having in their mass spectrum an interesting m/z (155.1) making that this 
compound could be a result of the break 7 of the synthetic cannabinoid. The peak 7 
corresponds to a molecule that has a m/z ratio of 75.1, meaning that it could be a 
resulting compound of the breaks 5 of the synthetic cannabinoid. The peak 6 is 
referent to a molecule that has also a special interest because of their m/z ratio of 
284.1 that could be a result of the breaks 5. The peaks 8 and 9 correspond to 
compounds that have m/z ratios 232.1 and 232.2 that might result of the break 8 of 
the initial molecule.  
 
Table 22: Possible resulting compounds of the combustion of the synthetic cannabinoid 
AM2201 2’-naphthyl isomer present in CM21 blends. 
 
 
 
 
Peak number Retention time 
(minutes) 
Interesting peak Break (number) 
1 5,382 89,1 6 
3 7,588 155,1 7 
4 11,340 89,1 6 
5 11,457 75,1 5 
5 11,457 89,1 6 
6 17,550 89,1 6 
6 17,550 284,1 5 
7 18,675 232,2 8 
9 20,480 232,1 8 
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Combustion products 
 
After an extensive analysis of the results obtained molecules that could possibly 
be combustion products of the synthetic cannabinoid AM2201 2’-naphthyl isomer are 
presented in the table 23. This result was obtained comparing the molecular weight of 
the resultant molecules obtained by the simulation of the breaks in the synthetic 
cannabinoid with the molecular weight of the identified compound in the resultant 
chromatogram of the combustion experiment. 
 
 
Table 23: Compounds resulting of the matching between the simulation of the breaks 
(theoretical approach) in the molecule of the synthetic cannabinoid AM2201 2’-naphthyl 
isomer and the compounds found in the chromatograms resulting of the combustion assay of 
the compound CM21. 
 
 
C5H11F 
 
1-fluoropentane 
 
 
 
 
 
C20H15NO 
 
 
 
(1-methyl-1H-indol-3-
yl)(naphthalene-2-yl)methanone 
 
 
 
 
C4H9F 
 
1-fluorobutane 
 
 
 
 
C11H8O 
 
2-naphthaldehyde 
 
 
 
 
 
C14H16FNO 
 
 
1-(5-fluoropentyl)-1H-indole-3-
carbaldehyde 
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4.2 Herbal incense: SCORPION ULTRASTRONG 
 
 
Figure 35: Comparison between chromatograms resulting of the injection of SCORPION 
ULTRASTRONG incense before (1) and after (2) the combustion. 
 
The first chromatogram presented in figure 35 is related to the injection of 2 µL 
of the solution prepared - 5mg of the sample SCORPION ULTRASTRONG dissolved in 1 
mL of methanol. This chromatogram serves as a reference for comparison with the 
chromatograms relative to the simulation of the combustion of these samples, giving 
rise to the appearance of combustion products of synthetic cannabinoids present in 
the herbal incense. Thus, the second chromatogram is related to the injection of 2 µL 
of the solution obtained after the extraction of the SPE cartridge with 2 mL of 
methanol and subsequent drying in a nitrogen flow, and resuspended in 100uL of 
methanol. Thus, it is possible to observe that after being subjected to heating, the 
sample undergoes several processes of transformation, leading to the formation of 
new products, as we will verify later, on a closer examination of the chromatogram in 
question.  
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4.2.1 Volatile contained in the SPE cartridge  
 
Figure 36: Chromatogram analysis of the injection of CM21 after the combustion and the main 
peaks found related to the combustion of the synthetic cannabinoids. 
 
In the chromatogram present in figure 36 it is possible to verify that, after the 
heating, there are a lot of new substances formed. The main peaks found in this 
chromatogram are: peak 1, with the retention time 6,873 minutes; peak 2, whose 
retention time is 7,469 minutes; peak 3, with retention time 18,910 minutes; peak 4, 
that appears at 20,512 minutes. Some of these peaks have an especial interest 
because of the coincidence of their m/z ratio with the m/z ratio of the molecules 
formed when the breaks in the synthetic cannabinoid are simulated. 
In the table 24, the main peaks are referred along with the synthetic 
cannabinoids precursors. The m/z ratios of the new found compounds were taken into 
account and were compared with the m/z ratio resultant of the breaks of the synthetic 
cannabinoid(s) (figure 37). Furthermore, it is also represented in the table the 
identification of the compounds by the swgdrug library. 
 
 
 
1 
 
2 
 
3 
 
4 
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Table 24: SCORPION ULTRASTRONG herbal incense analysis of the volatile contained in the SPE 
cartridge: main peaks founded and possible combustion products. 
 
 
 
 
 
 
Peak 
number 
 
Retention 
time 
 
m/z of the 
unknown 
compound 
 
Synthetic cannabinoid(s) that possibly 
originate this compound 
 
1 
 
6,873 
 
55, 111, 129, 
143, 184, 
215, 239, 323 
 
JWH-122 7-methylnaphthyl isomer 
 
2 
 
8,469 
 
57, 91, 219, 
341 
 
JWH-122 7-methylnaphthyl isomer 
 
3 
 
18,910 
 
115, 141, 
169, 212, 
241, 298 
 
 
JWH-122 7-methylnaphthyl isomer 
 
4 
 
20,512 
 
115, 169, 
232, 254, 
298, 374 
 
JWH-122 7-methylnaphthyl isomer 
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4.2.1.1 JWH-122 7-methylnaphthyl isomer (SYNTHETIC 
CANNABINOID 4) 
 
Simulations of breaks in the molecule – Identification of combustion 
products – theoretical approach 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 37: Simulations of breaks in the molecule JWH-122 7-methylnaphthyl isomer that could 
occur when the combustion process. 
 
 Each number refers to a simulation of a break in the initial molecule of the 
synthetic cannabinoid JWH-122 7-methylnaphthyl isomer (figure 37). In the table 25 is 
5 
2 
1 3 
4 
6 
7 
8 
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represented the molecular weight as a result of the referred break and the 
correspondent molecular formulation. 
 
Table 25: Resulting compounds of the simulation of breaks in the molecule JWH-122 7-
methylnaphthyl isomer that could occur when the combustion process. 
 
  
 In each assay it was obtained a chromatogram with the peaks that allows the 
study of the combustion products of the synthetic cannabinoids presents in the drugs 
used in this experiment.  
 The peaks represented are those corresponding to compounds whose 
compounds m/z ratio is coincident to the m/z ratio of some molecule resultant of the 
break of the initial molecule. In this way, the resultant molecule could possibly be a 
combustion product of the initial molecule, the synthetic cannabinoid. Thus, the peak 
2 of the chromatogram presented in the Figure 36 is referent to a compound with a 
Break number Resulting 
molecule (1) 
Molecular 
weight (1) 
Resulting 
molecule (2) 
Molecular 
weight (2) 
1 C20H14NO
● 
 
284,11 C5H11
● 71,09 
2 C21H16NO
● 
 
298,12 C4H9
● 57,07 
3 C22H18NO
● 
 
312,14 C3H7
● 43,05 
4 C23H20NO
● 
 
326,15 C2H5
● 29,04 
5 C24H22NO
● 
 
340,17 CH3 15,02 
6 C13H16N
● 
 
186,13 C12H9O
● 169,07 
7 C14H16NO
● 
 
214,12 C11H9
● 141,07 
8 C24H22NO
● 340,17 CH3 15,02 
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m/z ratio (57.1) that can probably be a result of the break 2 of the synthetic 
cannabinoid (Figure 37). The peaks 3 and 4 have in their mass spectrum a compound 
with an interesting m/z (169.1) making that this compound could be a result of the 
break 6 of the synthetic cannabinoid. The peak 4 has a molecule with a m/z ratio of 
298.2 meaning that could be a resulting compound of the break 2 of the synthetic 
cannabinoid.  
 
Table 26: Possible resulting compounds of the combustion of the synthetic cannabinoid JWH-
122 7-methylnaphthyl isomer present in SCORPION blends. 
 
 
Combustion products 
 
After an extensive analysis of the results obtained, molecules that could 
possibly be combustion products of the synthetic cannabinoid JWH-122 7-
methylnaphthyl isomer are represented in the table 27. These results were obtained 
comparing the molecular weight of the resultant molecules obtained by the simulation 
of the breaks in the synthetic cannabinoid (theoretical approach) with the molecular 
weight of the identified compound in the resultant chromatogram of the combustion 
experiment. 
 
 
 
Peak number Retention time 
(minutes) 
Molecular weight Break (number) 
2 8,469 57,1 2 
3 18,910 169,1 6 
4   20,512 169,1 6 
4 20,512 298,2 2 
86 
 
Table 27: Compounds resulting of the matching between the simulation of the breaks 
(theoretical approach) in the molecule of the synthetic cannabinoid JWH-122 7-
methylnaphthyl isomer and the compounds found in the chromatograms resulting of the 
combustion assay of the compound SCORPION. 
 
 
C4H10 
 
Butane 
 
 
 
 
C12H10O 
 
1-pentyl-1H-indole 
 
 
 
 
 
 
C11H10 
 
 
2-methylnaphtalene 
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4.3 Herbal incense: SHIVA ULTRASTRONG 
 
 
Figure 38: Comparison between chromatograms resulting from the injection of SHIVA 
ULTRASTRONG incense before (1) and after (2) the combustion. 
  
The first chromatogram presented in figure 38 corresponds to the injection of 2 
µL of the solution prepared - 5mg of the sample SHIVA ULTRASTRONG dissolved in 1 
mL of methanol. This chromatogram serves as a reference to compare with the 
chromatograms relative to the simulation of the combustion of these samples, giving 
rise to the appearance of combustion products of synthetic cannabinoids present in 
the herbal incense. Thus, the second chromatogram correspond to the injection of 2 µL 
of the solution obtained after the extraction of the SPE cartridge with 2 mL of 
methanol and subsequent drying in a nitrogen flow, and resuspended in 100uL of 
methanol. Thus, it is possible to observe that after being subjected to heating, the 
sample undergoes several processes of transformation, leading to the formation of 
new products, as we will verify later, on a closer examination of the chromatogram in 
question.  
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4.3.1 Volatile contained in the SPE cartridge 
 
 
 
Figure 39: Chromatogram analysis of the injection of CM21 after the combustion and the main 
peaks found related to the combustion of the synthetic cannabinoids. 
 
In the chromatogram present in the figure 39 it is possible to verify that, after 
the heating, there are a lot of new substances formed. The main peaks found in this 
chromatogram are: peak 1, with the retention time 11,338 minutes; peak 2, whose 
retention time is 11,455 minutes; peak 3, with retention time 17,555 minutes; peak 4, 
that appears at 18,670 minutes; peak 5 whose retention time is 18,892 minutes; peak 
6 appearing at 20,463 minutes; the peak 7, at 24,445 minutes and finally the peak 8 at 
25,189. Some of these peaks have an especial interest because of the coincidence of 
their m/z ratio with the m/z ratio of the molecules formed when the breaks in the 
synthetic cannabinoid are simulated. 
In table 28, the main peaks are referred along with the synthetic cannabinoids 
precursors. The m/z ratio of the new found compound is taken into account and is 
compared with the m/z ratio resultant of the breaks of the synthetic cannabinoid(s).  
 
6 
 
5 
 
4 
 
3 
 
2 
 
1 
 
7 
 
12 
 
11 
 
10 
 
9 
 
8 
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Table 28: SHIVA ULTRASTRONG herbal incense analysis of the volatile contained in the SPE 
cartridge: main peaks founded and possible combustion products. 
 
 
 
Peak 
number 
 
Retention 
time 
 
m/z of the 
unknown 
compound 
 
Synthetic cannabinoid(s) that possibly originate 
this compound 
 
1 
 
4,413 
 
60, 73, 87, 
115,158 
 
JWH-122 N-(4-pentenyl) analog 
 
2 
 
6,878 
 
55, 73, 83, 111, 
129, 143, 215 
 
JWH-122 N-(4-pentenyl) analog 
 
3 
 
7,591 
 
55, 99, 173, 217 
 
JWH-122 N-(4-pentenyl) analog 
 
4 
 
7,867 
 
 
91, 131, 162, 
236 
 
MAM2201 N-(-5-chloropentyl) analog 
 
5 
 
9,471 
 
67, 91, 115, 161, 
175, 189, 217 
 
MAM2201 N-(-5-chloropentyl) analog 
 
6 
 
11,338 
 
59, 75, 89 
 
MAM2201 or AM2201 
 
7 
 
11,455 
 
61, 75, 89, 99, 
113, 129, 141, 
154 
 
MAM2201 or AM2201 
 
8 
 
17,555 
 
241, 268 
 
MAM2201 or AM2201 
 
9 
 
18,670 
 
144, 232, 284, 
342 
 
MAM2201 or AM2201 
 
10 
 
18,892 
 
115, 141, 169, 
212, 298, 353 
 
MAM2201, AM2201 or  JWH-122 N-(4-
fluoropentyl) isomer 
 
11 
 
20,463 
 
115, 141, 169, 
232, 298, 374 
 
MAM2201; AM2201 or  JWH-122 N-(4-
fluoropentyl) isomer 
 
12 
 
24,445 
 
89, 115, 141 
169, 248, 298 
 
MAM2201; AM2201 or  JWH-122 N-(4-
fluoropentyl) isomer 
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4.3.1.1 AM2201 (SYNTHETIC CANNABINOID 5) 
 
Simulations of breaks in the molecule (theoretical approach) – 
Identification of combustion products  
  
 
 
 
 
 
 
 
 
 
 
 
 
  
Figure 40: Simulations of breaks in the molecule AM2201 that could occur when the 
combustion process. 
 
 Each number refers to a simulation of a break in the initial molecule of the 
synthetic cannabinoid AM2201. In the table 29 it is represented the molecular weight 
as a result of the referred break and the correspondent molecular formulation. 
1 
6 
5 
4 
3 
2 
8 7 
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Table 29: Resulting compounds of the simulation of breaks in the molecule AM2201 2'-
naphthyl isomer that could occur when the combustion process. 
 
 
 In each assay it was obtained a chromatogram with the peaks that allows the 
study of the combustion products of the synthetic cannabinoids presents in the drugs 
used in this study.  
 The peaks represented are those corresponding to compounds whose m/z 
ratio is coincident to the m/z ratio of some molecule resultant of the break of the 
initial molecule. In this way, the resultant molecule could possibly be a combustion 
product of the initial molecule, the synthetic cannabinoid. Thus, the peak 3 of the 
chromatogram presented in the Figure 39 is correspondent to a compound with a m/z 
ratio (155.1) that can probably be a result of the break 7 of the synthetic cannabinoid 
(Figure 40). In turn, the peak 6, 7 and 8 are correspondent to molecules having in their 
mass spectrum an interesting m/z (89.1) making that this compound could be a result 
of the break 6 of the synthetic cannabinoid. On the other hand, the peak 7 
Break number Resulting 
molecule (1) 
Molecular weight 
(1) 
Resulting 
molecule (2) 
Molecular weight 
(2) 
1 C24H22NO
● 
 
340,17 F 19,00 
2 C23H20NO
● 
 
326,15 CH2F
● 33,01 
3 C22H18NO
● 
 
312,14 C2H4 F
● 47,03 
4 C21H16NO
● 
 
299,13 C3H6F
● 61,05 
5 C20H14NO
● 
 
284,11 C4H8F
● 75,06 
6 C19H12NO
● 
 
270,09 C5H10F
● 89,08 
7 C13H15FN
● 
 
204,12 C11H7O
● 155,05 
8 C14H15FNO
● 232,11 C10H7
● 127,05 
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corresponds to a compound that has a m/z ratio of 75.1, meaning that it could be a 
resulting compound of the break 5 of the synthetic cannabinoid. The peaks 9 and 11 
are correspondent to molecules that also have a special interest because of their m/z 
ratio (232.1) that could be a result of the breaks 5.  
 
Table 30: Possible resulting compounds of the combustion of the synthetic cannabinoid 
AM2201 2'-naphthyl isomer present in SHIVA blends. 
 
 
 
Combustion products 
 
After an extensive analysis of the results obtained, molecules that could 
possibly be combustion products of the synthetic cannabinoid AM2201 are presented 
in the table 31. This result was obtained comparing the molecular weight of the 
resultant molecules obtained by the simulation of the breaks in the synthetic 
cannabinoid with the molecular weight of the identified compound in the resultant 
chromatogram of the combustion experiment. 
 
  
Peak number Retention time 
(minutes) 
Molecular weight Break (number) 
3 7,591 155,1 7 
6 11,338 89,1 6 
7 11,455 89,1 6 
7 11,455 75,1 5 
8 17,555 89,1 6 
9 18,670 232,1 8 
11 20,463 232,1 8 
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Table 31: Compounds resulting of the matching between the simulation of the breaks 
(theoretical approach) in the molecule of the synthetic cannabinoid AM2201 2'-naphthyl 
isomer and the compounds found in the chromatograms resulting of the combustion assay of 
the compound SHIVA. 
 
 
C4H9F 
 
1-fluorobutane 
 
 
 
C5H11F 
 
1-fluoropentane 
 
 
 
 
C14H16FNO 
 
 
1-(5-fluoropentyl)-1H-indole-3-
carbaldehyde 
 
 
 
C11H8O 
 
 
2-naphthaldeyde 
 
 
 
C10H8 
 
Naphthalene 
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4.3.1.2 MAM2201 (SYNTHETIC CANNABINOID 6) 
 
Simulations of breaks in the molecule (theoretical approach) – 
Identification of combustion products  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 41: Simulations of breaks in the molecule MAM2201 that could occur when the 
combustion process. 
 
 Each number refers to a simulation of a break in the initial molecule of the 
synthetic cannabinoid MAM2201 (figure 41). In the table 32 is represented the 
molecular weight as a result of the referred break and the correspondent molecular 
formulation. 
 
8 
2 
1 3 
4 
7 
9 
6 
5 
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Table 32: Resulting compounds of the simulation of breaks in the molecule MAM2201 N-(4-
fluoropentyl) isomer that could occur when the combustion process. 
 
Break number Resulting 
molecule (1) 
Molecular 
weight (1) 
Resulting 
molecule (2) 
Molecular 
weight (2) 
1 C24H21FNO
● 358,16 CH3 15,02 
2 C25H24NO
● 354,19 F● 19,00 
3 C23H20NO
● 326,15 C2H4F
● 47,03 
4 C22H18NO
● 312,14 C3H6F
● 61,05 
5 C21H16NO
● 298,12 C4H8F
● 75,06 
6 C20H14NO
● 284,11 C5H10F
● 89,08 
7 C13H15FN
● 204,12 C12H9O
● 169,07 
8 C12H15FN3
● 192,12 C13H10O
● 169,07 
9 C24H21FNO
● 358,16 CH3 15,02 
 
 
 In each assay it was obtained a chromatogram with the peaks that allows the 
study the combustion products of the synthetic cannabinoids presents in the drugs 
used in this study.  
 The peaks represented are those corresponding to compounds whose m/z 
ratio is coincident to the m/z ratio of some molecule resultant of the break of the 
initial molecule. In this way, the resultant molecule could possibly be a combustion 
product of the initial molecule, the synthetic cannabinoid. Thus, the peaks 6, 7 and 8 of 
the chromatogram presented in the Figure 39 have a chromatographic peak 
corresponding to compounds having a m/z ratio (89.1) that could probably be a result 
of the break 6 of the synthetic cannabinoid (Figure 41). In turn, the peak 7 correspond 
to a molecule having in their mass spectrum a m/z of 75.1, making that this compound 
could be a result of the break 5 of the synthetic cannabinoid. Finally, the peaks 10, 11 
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and 12 are correspondent to a compound with a common m/z ration of 169.1 meaning 
that could be a result of the break 8. 
 
Table 33: Possible resulting compounds of the combustion of the synthetic cannabinoid 
MAM2201 N-(4-fluoropentyl) isomer present in SHIVA blends. 
 
 
Combustion products 
 
After an extensive analysis of the results obtained, molecules that could 
possibly be combustion products of the synthetic cannabinoid MAM2201 are 
presented in the table 34. This result was obtained comparing the molecular weight of 
the resultant molecules obtained by the simulation of the breaks in the synthetic 
cannabinoid with the molecular weight of the identified compound in the resultant 
chromatogram of the combustion experiment. 
 
 
 
 
 
Peak number Retention time 
(minutes) 
Molecular weight Break (number) 
6 11,338 89,1 6 
7 11,455 75,1 5 
7 11,455 89,1 6 
8 17,555 89,1 6 
10 18,892 169,1 8 
11 20,463 169,1 8 
12 24,445 169,1 8 
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Table 34: Compounds resulting of the matching between the simulation of the breaks 
(theoretical approach) in the molecule of the synthetic cannabinoid MAM2201 and the 
compounds found in the chromatograms resulting of the combustion assay of the compound 
SHIVA. 
 
 
C4H9F 
 
2-fluorobutane 
 
 
 
C5H11F 
 
2-fluoropentane 
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4.3.1.3 JWH-122 N-(4-pentenyl) analog (SYNTHETIC CANNABINOID 2) 
 
Simulations of breaks in the molecule (theoretical approach) – 
Identification of combustion products 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Figure 42: Simulations of breaks in the molecule JWH-122 N-(4-pentenyl) analog that could 
occur when the combustion process. 
  
 Each number refers to a simulation of a break in the initial molecule of the 
synthetic cannabinoid JWH-122 N-(4-pentenyl) analog. In the table 35 is represented 
3 
6 
7 
4
1
1
1
1
1 
5 
8 
1 2 
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the molecular weight as a result of the referred break and the correspondent 
molecular formulation. 
 
Table 35: Resulting compounds of the simulation of breaks in the molecule JWH-122 N-(4-
pentenyl) analog that could occur when the combustion process. 
 
Break number Resulting 
molecule (1) 
Molecular weight 
(1) 
Resulting 
molecule (2) 
Molecular weight 
(2) 
1 C24H23NO
● 
 
341,18 CH2 14,02 
2 C23H20NO
● 
 
326,15 C2H3
● 27,02 
3 C22H18NO
● 
 
312,14 C3H5
● 41,04 
4 C21H16NO
● 
 
298,12 C4H7
● 55,05 
5 C20H14NO
● 
 
284,11 C5H9
● 69,07 
6 C13H14N
● 
 
184,11 C12H9O
● 169,07 
7 C14H14NO
● 
 
212,11 C11H9
● 141,07 
8 C24H20NO
● 338,15 CH3 15,02 
  
 In each assay it was obtained a chromatogram with the peaks that allows the 
study of the combustion products of the synthetic cannabinoids presents in the drugs 
used in this experiment.  
 The peaks represented are those corresponding to compounds whose m/z 
ratio is coincident to the m/z ratio of some molecule resultant of the break of the 
initial molecule. In this way, the resultant molecule could possibly be a combustion 
product of the initial molecule, the synthetic cannabinoid. Thus, the chromatographic 
peaks 1, 2 and 3 of the chromatogram presented in the Figure 39 are correspondent to 
a molecule with a m/z ratio (55.1) that can probably be a result of the break 4 of the 
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synthetic cannabinoid (Figure 42). In turn, the peak 10 correspond to a compound with 
two interesting m/z ratio, 169.1 and 212.1, meaning that it could be a resulting 
compound of the breaks 6 or 7 of the synthetic cannabinoid. Also the chromatographic 
peaks 11 and 12, are correspondent to compounds with a m/z ratio of 169.1, might be 
resulting compounds of the break 6 of the initial molecule.  
 
Table 36: Possible resulting compounds of the combustion of the synthetic cannabinoid JWH-
122 N-(4-pentenyl) analog present in SHIVA blends. 
 
 
Combustion products 
 
After an extensive analysis of the results obtained molecules that could possibly 
be combustion products of the synthetic cannabinoid JWH-122 N-(4-pentenyl) analog 
presented in the table 37. This result was obtained comparing the molecular weight of 
the resultant molecules obtained by the simulation of the breaks in the synthetic 
cannabinoid with the molecular weight of the identified compound in the resultant 
chromatogram of the combustion experiment. 
 
Peak number Retention time 
(minutes) 
Molecular weight Break (number) 
1 4,413 55,1 4 
2 6,878 55,1 4 
3 7,591 55,1 4 
10 18,892 212,1 7 
10 18,892 169,1 6 
11 20,463 169,1 6 
12 24,445 169,1 6 
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Table 37: Compounds resulting of the matching  between the simulation of the breaks 
(theoretical approach) in the molecule of the synthetic cannabinoid JWH-122 N-(4-pentenyl) 
analog and the compounds found in the chromatograms resulting of the combustion assay of 
the compound SHIVA. 
 
 
 
  
 
 
C12H10O 
 
 
4-methyl-1-
naphtalenecarboxaldehyde 
 
 
 
C4H8 
 
1-butane 
 
 
 
 
 
C14H15NO 
 
 
1-(pent-4-en-1-yl)-1H-indole-3-
carbaldehyde 
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4.3.1.4 MAM2201 N-(-5-chloropentyl) analog (SYNTHETIC 
CANNABINOID 7) 
 
Simulations of breaks in the molecule (theoretical approach) – 
Identification of combustion products  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Each number refers to a simulation of a break in the initial molecule of the 
synthetic cannabinoid MAM2201 N-(-5-chloropentyl) analog. In the table 38 it is 
represented the molecular weight as a result of the referred break and the 
correspondent molecular formulation.  
 
2 3 4 
5 
7 
6 
8 
9 
1 
Figure 43: Simulations of breaks in the molecule MAM2201 N-(5-chloropentyl) analog that could 
occur when the combustion process. 
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Table 38: Resulting compounds of the simulation of breaks in the molecule MAM2201 N-(-5-
chloropentyl) analog that could occur when the combustion process. 
 
Break number Resulting 
molecule (1) 
Molecular 
weight (1) 
Resulting 
molecule (2) 
Molecular 
weight (2) 
1 C25H24NO
● 354,19 Cl 34,97 
2 C24H21NO
● 340,17 CH2Cl
● 48,98 
3 C23H20NO
● 326,15 C2H4Cl
● 63,00 
4 C22H18NO
● 312,14 C3H6Cl
● 77,02 
5 C21H16NO
● 298,12 C4H8Cl
● 91,03 
6 C20H14NO
● 284,11 C5H10Cl
● 105,05 
7 C13H15ClN
● 220,09 C12H9O
● 169,07 
8 C14H15ClNO
● 248,08 C11H9
● 141,07 
9 C24H21ClNO
● 374,13 CH3 15,02 
 
 
 In each assay it was obtained a chromatogram with the peaks that allows the 
study of the combustion products of the synthetic cannabinoids presents in the drugs 
used in this study.  
 The peaks represented are those corresponding to molecules whose m/z ratio 
is coincident to the m/z ratio of some molecule resultant of the break of the initial 
molecule. In this way, the resultant molecule could possibly be a combustion product 
of the initial molecule, the synthetic cannabinoid. Therefore, the peaks 4 and 5 of the 
chromatogram presented in the Figure 39 has a chromatographic peak corresponding 
to a compound having a m/z ratio (91.1) that can probably be a result of the break 5 of 
the synthetic cannabinoid (Figure 43). The peak 11 is referent to a compound having in 
their mass spectrum a m/z of 169.1, making that this compound could be a result of 
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the break 7 of the synthetic cannabinoid. Finally, the peak 12 is correspondent to a 
molecule that has a m/z ration of 141.1 meaning that could be a result of the break 8. 
 
Table 39: Possible resulting compounds of the combustion of the synthetic cannabinoid 
MAM2201 N-(-5-chloropentyl) analog present in SHIVA blends. 
 
 
Combustion products 
 
After an extensive analysis of the results obtained, molecules that could 
possibly be combustion products of the synthetic cannabinoid MAM2201 N-(-5-
chloropentyl) analog are presented in the table 40. This result was obtained comparing 
the molecular weight of the resultant molecules obtained by the simulation of the 
breaks in the synthetic cannabinoid with the molecular weight of the identified 
compound in the resultant chromatogram of the combustion experiment. 
 
  
Peak number Retention time 
(minutes) 
Molecular weight Break (number) 
4 7,867 91,1 5 
5 9,471 91,1 5 
11 20,442 169,1 7 
12 24,434 141,1 8 
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Table 40: Compounds resulting of the matching between the simulation of the breaks 
(theoretical approach) in the molecule of the synthetic cannabinoid MAM2201 and the 
compounds found in the chromatograms resulting of the combustion assay of the compound 
SHIVA. 
 
 
 
C4H9Cl 
 
 
1-Chlorobutane 
 
 
 
 
 
C12H10O 
 
 
4-methyl-1-
naphtalenecarboxaldehyde 
 
 
 
 
C11H10 
 
 
2-methylnaphtalene 
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CHAPTER III: 
DISCUSSION 
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In order to mimic what happens when consumers smoke these drugs, and the 
effects of high temperatures, several techniques were tested aiming the identification 
of compounds produced during the combustion process of the synthetic cannabinoids. 
Initially, vials containing the investigation samples were put inside a muffle furnace, 
however, they could not be screwed because they have a plastic lid, which melted 
during the heating. In this way, the new volatile compounds formed were lost during 
its formation. As result, only ashes obtained were analyzed showing a decrease of the 
synthetic cannabinoids concentration dependent on the temperature. 
Later, due to the fail of the experiment described to get volatiles, another 
method (in a muffle apparatus – Chapter 1 – section 2.1) was tested using the glass 
screwed ampoules. This method enables the retention of the new compounds formed 
inside the ampoule. However, due to the fact that the glass is highly sensitive to high 
temperatures, in the majority of the cases, the ampoule melted (above 400ºC), and 
volatiles were lost. This technique could work if the glass material were more resistant 
to high temperatures. Anyway, results were analyzed showing also a decrease of the 
synthetic cannabinoids parallel with the increase of the temperature.  
Both techniques described below were tested in a similar way, heating the 
samples until 600ºC. Based in internet reports, the synthetic cannabinoids combustion 
temperature varies from 450ºC to 550ºC. Since no studies in this topic are available in 
scientific literature, this experiment was based in the mentioned information. 
After that, a new technique was developed aiming to get volatiles, as described 
in the Chapter 1 – section 2.2. For this purpose an apparatus was developed in order to 
retain in a SPE column volatile compounds formed during the combustion process. 
The work was divided in two steps, first the identification of the cannabinoids 
present in each sample, second, after submitted by two different methods samples to 
high temperatures, samples were dissolved in methanol and analyzed by GC-MS.  
Chromatographic peaks obtained were identified by using mass spectra 
libraries for synthetic cannabinoids (swgdrug library). For combustion products each 
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mass spectrum was compared to m/z obtained by theoretical fragmentation of the 
initial cannabinoid. 
According to the results previously presented we are able to identify seven 
different synthetic cannabinoids in the three commercial products bought in an on-line 
shop: 
- In the herbal incense CM21 were found the follow synthetic cannabinoids: 
MAM2201 N-(-4-fluoropentyl) isomer, JWH-122 N-(4-pentenyl) analog and 
AM2201 2’-naphthyl isomer; 
- In the sample SCORPION ULTRASTRONG the synthetic cannabinoid found 
was JWH-122 7-methylnaphthyl; 
- In the herbal incense SHIVA ULTRASTRONG were founded the next 
synthetic cannabinoids: JWH-122 N-(4-pentenyl) analog (also present in the 
sample CM21), AM2201, MAM2201 and MAM2201 N-(-5-chloropentyl) 
analog.  
 
To the accomplishment of the objective of this experiment, identify the 
combustion products of the synthetic cannabinoids present, theoretical breaks were 
simulated in each cannabinoids. Subsequently, based on the chromatograms obtained 
from the injection of the samples obtained from the extraction of the SPE column after 
the combustion methodology, the peaks of interest were selected and the ions (m/z) 
of these chromatographic peaks were analyzed. Thereafter, it was performed a 
comparison between the peaks referred and the ratio mass/charge obtained by the 
simulation of the breaks in the initial compound leading to the conclusion that these 
molecules could possibly be the result from the heating of the starting compound, 
namely the products of combustion thereof. 
 Thus, fulfilled the described above, according to the results obtained, 
concerning to the blend CM21, the molecules C4H9F (2-fluorobutane), C5H11F (2-
fluoropentane), C20H15NO (1h-inden-2-yl)(4-methylnaphthalen-1-yl)methano, C12H10O 
(4-methyl-1-naphtaldehyde), C14H16FNO (1-(4-fluoropentyl)-3-methyl-1H-indole) and 
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C11H10 (1-methylnaphthalene) can be combustion products of the synthetic 
cannabinoid MAM2201 N-(4-fluoropentyl) isomer, resulting of the breaks 5, 6, 6, 7, 8 
and 8, respectively, in the original molecule.  
 In respect to the cannabinoid JWH-122 N-(4-pentenyl) analog, also concerning 
to the blend CM21, the molecules C20H14NO (3-(1-(4-methylnaphthalen-1-yl)vinyl)-1-
(pent-4-en-1-yl)indoline), C4H8 (but-1-ene) and C12H10O (4-methyl-1-naphtaldehyde), 
can also be combustion products, resultant of the breaks 5, 4 ad 6. Still referring to 
CM21, the cannabinoid AM2201 2’naphthyl isomer can have as combustion products 
C5H11F, C20H15NO, C4H9F, C11H8O, C14H16FNO and C19H20FNO, ensuing of the breaks 6, 5, 
4, 7 and 8. 
In relation to herbal incense SCORPION, the molecules C4H10 (Butane), C12H10O 
(1-pentyl-1H-indole) and C11H10 (2-methylnaphtalene), can be combustion products of 
the synthetic cannabinoid JWH-122 7-methylnaphtyl isomer, resultant of the breaks 2, 
6 and 7, respectively. 
Relating to the blend SHIVA, the molecules C4H9F (2-fluorobutane) and C5H11F 
(2-fluoropentane) may be combustion products of the synthetic cannabinoid 
MAM2201 N-(4-fluoropentyl) isomer, resulting of the breaks 5 and 6, correspondingly. 
Concerning to the cannabinoid JWH-122 N-(4-pentenyl) analog, the molecules C12H10O 
(4-methyl-1-naphtalenecarboxaldehyde), C4H8 (1-butane) and C14H15NO (1-(pent-4-en-
1-yl)-1H-indole-3-carbaldehyde) can also be combustion products, resultant of the 
breaks 6, 4 and 7. Still referring to SHIVA, the cannabinoid AM2201 can have as 
combustion products the C4H9F (2-fluorobutane), C5H11F (2-fluoropentane), C14H16FNO 
(1-(5-fluoropentyl)-1H-indole-3-carbaldehyde), C11H7O (2-naphthaldehyde) and C10H8 
(naphthalene) resultant of the breaks 5, 6, 8, 7 and 8. Finally, the synthetic 
cannabinoid MAM2201 N-(-5-chloropentyl) analog has as combustion products C4H9Cl 
(1-chlorobutane), C12H10O (4-methyl-1-naphtalenecarboxaldehyde) and C11H10 2-
methylnaphtalene) resulting of the breaks 5, 7 and 8 of the initial molecule. 
Most of the molecules characterized as combustion products of the synthetic 
cannabinoids are not well-known or little studied. In this way, the effects of each one 
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in the human organism is difficult to predict. Nevertheless, some toxicological effects 
were related in relation to some known molecules as shown in the table 41.  
Table 41: Effects and toxicity of the resulting compounds from the combustion of synthetic 
cannabinoids. 
 
Compound Effects Toxicity 
2-chlorobutane Hazardous in case of skin or eye 
contact, ingestion and inhalation. 
No references to any toxicological 
development. 
2-fluoropentane Specific therapeutic activities of 
chemical compounds and medical 
preparations. 
No references. 
4-methyl-1-
naphtaldehyde 
Skin and mucous membranes irritant 
and has an irritant effect to the eyes. 
No references. 
1-methylnaphtalene May cause skin and eye irritation, 
photosensitization Inhalation of the 
vapors may produce airway irritation, 
headache, nausea, vomiting, extensive 
sweating, weakness and collapse. 
Dysuria, hematuria and the acute 
hemolytic reaction were also related. 
Ingestion may lead to systemic 
poisoning involving the 
gastrointestinal tract, kidneys and 
blood-forming tissue. 
But-1-ene may It is central nervous system depressant 
in high concentration. May cause 
asphyxia. On direct eye and skin 
contact can cause burns and frostbite. 
It has a low acute toxicity. 
Butane In low concentrations has not been 
reported to cause adverse effects in 
humans. It is anesthetic to both 
humans and experimental animals.  
Unexpected death or critical effects 
may occur when inhaled at high 
concentrations. Effects on the central 
nervous system in chronically exposed 
individuals were related. 
 
1-pentyl-1h-indole Is used for specific therapeutic activity 
of chemical compounds or medicinal 
preparations as anti-infective, i.e. 
antibiotic, antiseptic and 
chemotherapeutic. 
No references. 
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2-methylnaphtalene Inhalation exposure can cause cough. 
It is skin, eyes, mucous membranes 
and upper respiratory tract irritating. 
May cause headaches, nausea, 
vomiting, diarrhea, anemia, jaundice, 
euphoria, dermatitis and visual 
disturbances. 
Convulsions and comatose may occur. 
2-fluorobutane May be harmful if inhaled causing 
respiratory tract irritation and if 
swallowed. Causes skin and eye 
irritation. 
No references. 
2-naphthaldehyde May cause eye irritation and may be 
harmful if absorbed through skin. Is 
also harmful if inhaled, causing lungs 
and respiratory tract irritation, and if 
swallowed. Symptoms of 
overexposure may be headache, 
dizziness, tiredness, nausea and 
vomiting. 
Higher exposure causes 
unconsciousness. Severe overexposure 
can result in injury or death. 
 
1-chlorobutane Causes irritation to the respiratory 
tract. May cause coughing, shortness 
of breath. High concentrations have a 
narcotic effect. Also causes irritation to 
the gastrointestinal tract, may include 
symptoms as nausea, vomiting and 
diarrhea. Causes irritation to skin and 
eye. 
 
May causes systemic poisoning. Similar 
compounds demonstrate toxic effects 
after repeated exposures too low to 
result in acute effects. Investigated as 
carcinogenic and mutagenic. 
Naphtalene Exposure by inhalation, ingestion, and 
dermal contact is associated with 
hemolytic anemia, damage to the liver 
and lungs, and neurological damage. 
Symptoms of acute exposure include 
headache, nausea, vomiting, diarrhea, 
malaise, confusion, anemia, jaundice, 
convulsions, and coma.  
May cause laryngeal carcinomas or 
neoplasms of the pylorus and cecum.  
An increased number of 
alveolar/bronchiolar adenomas and 
carcinomas were reported by 
inhalation exposure.  
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 The toxicological properties of the majority of the products referred have not 
been fully determined. Most of them do not present mutagenic, carcinogenic or 
teratogenic effects, reproductive toxicity or developmental toxicity, only presenting 
irritation when exposed, as the case of 2-chlorobutane and 4-methyl-1-
naphthaldehyde. However, a few of them, as the case of naphthalene and 1-
chlorobutane seem to be highly prejudicial to human health due to their carcinogenic 
and mutagenic properties. In turn, compounds as 2-fluoropentane and 1-pentyl-1H-
indole are used for medicinal purposes, may provide a good sensation to their users, 
for example, functioning as analgesics. Compounds such as 2-fluorobutane, 1-
methylnaphtalene, butane, 2-methylnaphthalene and 2-naphthaldehyde with known 
toxicity, consumption in high doses can lead to the death or several problems as injury 
and affects the central nervous system. 
The compounds C20H14NO (3-(1-(4-methylnaphthalen-1-yl)vinyl)-1-(pent-4-en-1-
yl)indoline), C20H15NO (1h-inden-2-yl)(4-methylnaphthalen-1-yl)methano, C14H16FNO (1-
(4-fluoropentyl)-3-methyl-1H-indole), C14H15NO (1-(pent-4-en-1-yl)-1H-indole-3-
carbaldehyde), C14H16FNO (1-(5-fluoropentyl)-1H-indole-3-carbaldehyde), C12H10O (4-
methyl-1-naphtalenecarboxaldehyde), also identified as combustion products, are not 
described in literature, therefore toxicological information cannot be present. 
Although the knowledge of toxicological effects of some of the compounds 
described, the real danger or toxicity cannot be proved because the lethal quantities 
are not known and a quantitative analysis was not realized, thus, the concentration of 
new substances formed during the combustion process is not elucidated. For the 
accomplishment of this procedure, patterns should be used. 
In this experiment, the identification of the compounds is based in a theoretical 
simulation. For better results, the detected substances should be compared with 
patterns instead of mass spectra. However, this analysis was not possible because 
patterns of the synthetic cannabinoids in study were not available. 
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CHAPTER IV: 
CONCLUSIONS AND FUTURE 
PERSPECTIVES 
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In order to mimic what happens when consumers smoke synthetic 
cannabinoids, easily available in smartshops and on-line, the effect of high 
temperatures in the production of new compounds was investigated. For this purpose, 
several techniques were tested aiming the identification of the compounds produced 
during the combustion process of the synthetic cannabinoids. Hence, the development 
of a methodology that allows the knowledge of the combustion products of the 
synthetic cannabinoids becomes helpful for ulterior study of the toxicity of these 
substances.  
Some methods have been developed and tested during this research, 
therefore, only in one of them conclusive results have been obtained. Initially, a muffle 
furnace apparatus was used to heat the samples until their combustion temperature, 
first with open vials, whose results were not conclusive because the volatile 
compounds were lost during the heating of the sample; next, glass screwed ampoules 
were used and due to the sensitivity of this kind of material, the glass melted and the 
majority of the volatiles were equally lost. It can be shown a decrease of the synthetic 
cannabinoids concentration dependent on the temperature (1000C to 6000C). 
Finally, a developed combustion apparatus allowing the simulation of the 
combustion process of the synthetic cannabinoids enabled the identification of the 
new products formed. Numerous compounds were detected and by the theoretical 
chemical fragmentation their identification becomes possible. For the majority of 
compounds identified were not found in literature toxicity studies. However for a few, 
some effects are described in human body. Compounds as naphthalene and 1-
chlorobutane were identified as combustion products of synthetic cannabinoids, 
showing that when smoked can be really harmful due to their action in the human 
body. The majority of the other identified compounds are equally harmful, however 
they are less toxic than the previous referred. 2-fluoropentane and 1-pentyl-1H-indole 
were also identified as combustion products but with a different effect in the 
organism. These compounds are used with medicinal purposes, may provide beneficial 
sensations when consumed since their analgesic properties.  
118 
 
Other studies could be done in this area in a way of obtain better results, using 
other sophisticated techniques as the case of NMR or LC-MS, as described in the 
chapter I of this dissertation. The muffle furnace method, tested during this 
experiment, could also be a good technique to simulate the combustion process of 
synthetic cannabinoids, but a temperature resistant material should be used. 
The formal identification of each compound detected with standards will be of 
great interest to quantify these compounds as mentioned before some have 
dangerous consequences to human health.  
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